<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE Publisher PUBLIC "-//Springer-Verlag//DTD A++ V2.4//EN" "http://devel.springer.de/A++/V2.4/DTD/A++V2.4.dtd">
<Publisher>
  <PublisherInfo>
    <PublisherName>Springer New York</PublisherName>
    <PublisherLocation>New York, NY</PublisherLocation>
    <PublisherImprintName>Springer</PublisherImprintName>
    <PublisherLogo>
      <Figure Category="Standard" Float="No" ID="Figa">
        <MediaObject>
          <ImageObject Color="BlackWhite" FileRef="MediaObjects/978-1-60327-829-4_BookFrontmatter_Figa_HTML.png" Format="PNG" Rendition="HTML" Type="Linedraw"/>
        </MediaObject>
      </Figure>
    </PublisherLogo>
  </PublisherInfo>
  <Book Language="En">
    <BookInfo BookProductType="Contributed volume" ContainsESM="No" Language="En" MediaType="eBook" NumberingStyle="ChapterOnly" OutputMedium="All" TocLevels="0">
      <BookID>978-1-60327-829-4</BookID>
      <BookTitle>Drug Management of Prostate Cancer</BookTitle>
      <BookDOI>10.1007/978-1-60327-829-4</BookDOI>
      <BookTitleID>158057</BookTitleID>
      <BookPrintISBN>978-1-60327-831-7</BookPrintISBN>
      <BookElectronicISBN>978-1-60327-829-4</BookElectronicISBN>
      <CatalogingInformation Library="LOC">Library of Congress Control Number: 2010936435</CatalogingInformation>
      <BookChapterCount>37</BookChapterCount>
      <BookCopyright>
        <CopyrightHolderName>Springer Science+Business Media, LLC</CopyrightHolderName>
        <CopyrightYear>2010</CopyrightYear>
        <CopyrightStandardText Country="US" Language="En">All rights reserved. This work may not be translated or copied in whole or in part without the written permission of the publisher (Springer Science+Business Media, LLC, 233 Spring Street, New York, NY 10013, USA), except for brief excerpts in connection with reviews or scholarly analysis. Use in connection with any form of information storage and retrieval, electronic adaptation, computer software, or by similar or dissimilar methodology now known or hereafter developed is forbidden.</CopyrightStandardText>
        <TrademarkQualifierText Country="US" Language="En">The use in this publication of trade names, trademarks, service marks, and similar terms, even if they are not identified as such, is not to be taken as an expression of opinion as to whether or not they are subject to proprietary rights.</TrademarkQualifierText>
        <SpringerReferenceLine Country="US" Language="En">Springer is part of Springer Science+Business Media (www.springer.com)</SpringerReferenceLine>
        <SpringerLocationsLine>Springer New York Dordrecht Heidelberg London</SpringerLocationsLine>
      </BookCopyright>
      <PaperInfo Language="En">Printed on acid-free paper</PaperInfo>
      <BookSubjectGroup>
        <BookSubject Code="SCH" Type="Primary">Medicine &amp; Public Health</BookSubject>
        <BookSubject Code="SCH33160" Priority="1" Type="Secondary">Oncology</BookSubject>
        <BookSubject Code="SCH62002" Priority="2" Type="Secondary">Urology</BookSubject>
        <BookSubject Code="SCH33002" Priority="3" Type="Secondary">Internal Medicine</BookSubject>
        <SubjectCollection Code="SUCO11650">Medicine</SubjectCollection>
      </BookSubjectGroup>
    </BookInfo>
    <BookHeader>
      <EditorGroup>
        <Editor AffiliationIDS="AffID1">
          <EditorName DisplayOrder="Western">
            <GivenName>William D.</GivenName>
            <GivenName>D.</GivenName>
            <FamilyName>Figg</FamilyName>
          </EditorName>
          <Contact>
            <Phone>301402-3622</Phone>
            <Fax>301402-8606</Fax>
            <Email>wdfigg@helix.nih.gov</Email>
          </Contact>
        </Editor>
        <Editor AffiliationIDS="AffID2">
          <EditorName DisplayOrder="Western">
            <GivenName>Cindy H.</GivenName>
            <GivenName>H.</GivenName>
            <FamilyName>Chau</FamilyName>
          </EditorName>
          <Contact>
            <Email>chauc@mail.nih.gov</Email>
          </Contact>
        </Editor>
        <Editor AffiliationIDS="AffID3">
          <EditorName DisplayOrder="Western">
            <GivenName>Eric J.</GivenName>
            <GivenName>J.</GivenName>
            <FamilyName>Small</FamilyName>
          </EditorName>
          <Contact>
            <Phone>415/353-7171</Phone>
            <Email>smalle@medicine.ucsf.edu</Email>
          </Contact>
        </Editor>
        <Affiliation ID="AffID1">
          <OrgDivision>Medical Oncology Branch</OrgDivision>
          <OrgName>NIH National Cancer Institute</OrgName>
          <OrgAddress>
            <Street>Rockville Pike 9000</Street>
            <City>Bethesda</City>
            <Postcode>20892</Postcode>
            <State>Maryland</State>
            <Country>USA</Country>
          </OrgAddress>
        </Affiliation>
        <Affiliation ID="AffID2">
          <OrgDivision>Medical Oncology Branch</OrgDivision>
          <OrgName>NIH National Cancer Institute</OrgName>
          <OrgAddress>
            <Street>Rockville Pike 9000</Street>
            <City>Bethesda</City>
            <Postcode>20892</Postcode>
            <State>Maryland</State>
            <Country>USA</Country>
          </OrgAddress>
        </Affiliation>
        <Affiliation ID="AffID3">
          <OrgDivision>School of Medicine, Dept. Urology</OrgDivision>
          <OrgName>University of California, San Francisco</OrgName>
          <OrgAddress>
            <Street>Divisadero Street 1600</Street>
            <City>San Francisco</City>
            <Postcode>94115</Postcode>
            <State>California</State>
            <Country>USA</Country>
          </OrgAddress>
        </Affiliation>
      </EditorGroup>
    </BookHeader>
    <BookFrontmatter>
      <BookFrontmatterInfo>
        <BookFrontmatterFirstPage>i</BookFrontmatterFirstPage>
        <BookFrontmatterLastPage>xvii</BookFrontmatterLastPage>
      </BookFrontmatterInfo>
      <BodyFrontmatter>
        <Preface>
          <PrefaceInfo>
            <PrefaceTitle Language="En">Preface</PrefaceTitle>
          </PrefaceInfo>
          <AuthorGroup>
            <Author>
              <AuthorName DisplayOrder="Western">
                <GivenName>William</GivenName>
                <GivenName>D.</GivenName>
                <FamilyName>Figg</FamilyName>
              </AuthorName>
            </Author>
            <Author>
              <AuthorName DisplayOrder="Western">
                <GivenName>Cindy</GivenName>
                <GivenName>H.</GivenName>
                <FamilyName>Chau</FamilyName>
              </AuthorName>
            </Author>
            <Author>
              <AuthorName DisplayOrder="Western">
                <GivenName>Eric</GivenName>
                <GivenName>J.</GivenName>
                <FamilyName>Small</FamilyName>
              </AuthorName>
            </Author>
          </AuthorGroup>
          <Body>
            <Para TextBreak="No">Prostate cancer is the most common noncutaneous malignancy and the second leading cause of cancer deaths among men in the United States. It is a critical public health problem and remains incurable in the metastatic setting with mortality that usually occurs as a result of castration-resistant disease.</Para>
            <Para TextBreak="No">Since Huggins and Hodges’ report of the dramatic clinical effects of suppressing serum testosterone levels in men with advanced prostate cancer in 1941, hormone therapy (also called androgen deprivation therapy [ADT]) has become widely accepted as the mainstay of therapy for the treatment of advanced prostate cancer. ADT combined with radiation therapy is a standard of care in the treatment of men with locally advanced prostate cancer on the basis of evidence that shows improved survival. The role of ADT in the management of prostate cancer is controversial in that it is also used for other prostate cancer states (such as in men with biochemical recurrence after radical prostatectomy or lymph node metastases) even though the clinical effects of hormone therapy in these other settings have not been definitively proven to be beneficial. Hence the first part of this volume will focus on the role of hormone therapy in the management of advanced prostate cancer and address the controversies relevant to the role of ADT, including the time to initiate ADT, optimum duration of ADT, the benefits of combined androgen blockade, the role of intermittent ADT, and the benefits of secondary ­hormonal therapies.</Para>
            <Para TextBreak="No">In men whose cancer is no longer responding to hormone therapy, the treatment paradigm is shifted toward chemotherapy and other investigational options. In 2004, two landmark trials using docetaxel-based chemotherapy demonstrated for the first time a survival benefit in metastatic, castration-resistant prostate cancer. Research has revealed several distinct mechanisms of castration-resistant disease that may converge in patients with disease progression on ADT. Many approaches are currently being evaluated to improve the treatment of this condition and these findings have identified several potential targets for therapeutic intervention. These include drugs that are more active or less toxic chemotherapy agents; drugs that induce androgen deprivation; drugs that target the androgen receptor and/or androgen synthesis; drugs that target specific pathways, including angiogenesis and tyrosine kinase inhibitors, endothelin antagonists and matrix metalloproteinase inhibitors; and immunologic approaches. Many of these agents seem promising and the rationale and efficacy of these emerging therapies remain to be validated in future clinical trials.</Para>
            <Para TextBreak="No">In light of a growing array of existing and novel treatment options, this book was undertaken to capture the multidisciplinary care approach to the drug management of prostate cancer in order to optimize survival and quality of life for the patients. At this unique juncture in the treatment of prostate cancer, current standard and investigational treatment options for this disease are discussed, including hormone therapy and chemotherapy as well as rapidly evolving therapies in phase II/III trials involving antiangiogenic therapies, immunomodulatory agents, and nuclear receptor targets. It is divided into seven sections, preceded by an introduction that discusses the cell biology and molecular targets of prostate cancer. Part I describes the role of androgens and androgen deprivation therapy in prostate cancer and the several types of hormone therapy used to treat advanced prostate cancer, including luteinizing hormone-releasing hormone agonists and antagonists, and anti-androgens. Androgen receptor biology and the pharmacogenetics of the androgen metabolic pathway are also presented. Part II discusses the role of chemotherapy in prostate cancer including standard and investigational approaches as well as the clinical pharmacology and pharmacogenetics of these agents. Part III introduces the concept of angiogenesis in prostate cancer by discussing the principles of antiangiogenic therapy, investigational angiogenesis inhibitors, and the pharmacogenetics of angiogenesis. Part IV focuses on the pathophysiology of prostate cancer bone metastasis and the agents used at this stage of the disease process. Part V continues on to describe the role of immunotherapy for advanced prostate cancer including immunotherapeutics and vaccine approaches. In Part VI, chemoprevention strategies for prostate cancer are discussed. The last section of the book, Part VII, looks at the overall drug and technological development efforts and challenges in prostate cancer. As such, this book is a comprehensive, concisesummary of the ­pharmacological treatments of prostate cancer detailing knowledge of both conventional and emerging drug therapies. The chapters describe state-of-the-art information that will be appropriate for medical students, physicians in training, physicians, scientists, and members of the pharmaceutical industry. As advances in understanding the biology of prostate cancer and the mechanisms of castration-resistant disease continue over the next decade, novel drug ­discovery and development efforts will translate into emerging treatment paradigms in the therapeutic management of prostate cancer.</Para>
            <Para TextBreak="No">Lastly, we would like to thank our colleagues for providing their timely and important chapters. Our task of compiling this book was made easy by their high-quality contributions.</Para>
          </Body>
        </Preface>
        <Toc>
          <Heading>Contents</Heading>
          <TocChapter>
            <TocEntry PageNumber="1">
              <ExternalRef>
                <RefSource>1. Cell Biology of Prostate Cancer and Molecular Targets</RefSource>
                <RefTarget Address="10.1007/978-1-60327-829-4_1" TargetType="DOI"/>
              </ExternalRef>
            </TocEntry>
            <Author>
              <AuthorName DisplayOrder="Western">
                <GivenName>Martin</GivenName>
                <GivenName>E.</GivenName>
                <FamilyName>Gleave</FamilyName>
              </AuthorName>
            </Author>
            <Author>
              <AuthorName DisplayOrder="Western">
                <GivenName>Michael</GivenName>
                <GivenName>E.</GivenName>
                <FamilyName>Cox</FamilyName>
              </AuthorName>
            </Author>
            <Author>
              <AuthorName DisplayOrder="Western">
                <GivenName>Yuzhuo</GivenName>
                <FamilyName>Wang</FamilyName>
              </AuthorName>
            </Author>
          </TocChapter>
          <TocPart>
            <TocEntry>Part I. Hormone Therapy</TocEntry>
            <TocChapter>
              <TocEntry PageNumber="27">
                <ExternalRef>
                  <RefSource>2. Luteinizing Hormone-Releasing Hormone and its Agonistic, Antagonistic, and Targeted Cytotoxic Analogs in Prostate Cancer</RefSource>
                  <RefTarget Address="10.1007/978-1-60327-829-4_2" TargetType="DOI"/>
                </ExternalRef>
              </TocEntry>
              <Author>
                <AuthorName DisplayOrder="Western">
                  <GivenName>Andrew</GivenName>
                  <GivenName>V.</GivenName>
                  <FamilyName>Schally</FamilyName>
                </AuthorName>
              </Author>
              <Author>
                <AuthorName DisplayOrder="Western">
                  <GivenName>Norman</GivenName>
                  <GivenName>L.</GivenName>
                  <FamilyName>Block</FamilyName>
                </AuthorName>
              </Author>
            </TocChapter>
            <TocChapter>
              <TocEntry PageNumber="41">
                <ExternalRef>
                  <RefSource>3. Nuclear Receptor Coregulators: Promising Therapeutic Targets for the Treatment of Prostate Cancer</RefSource>
                  <RefTarget Address="10.1007/978-1-60327-829-4_3" TargetType="DOI"/>
                </ExternalRef>
              </TocEntry>
              <Author>
                <AuthorName DisplayOrder="Western">
                  <GivenName>Hannelore</GivenName>
                  <GivenName>V.</GivenName>
                  <FamilyName>Heemers</FamilyName>
                </AuthorName>
              </Author>
              <Author>
                <AuthorName DisplayOrder="Western">
                  <GivenName>Donald</GivenName>
                  <GivenName>J.</GivenName>
                  <FamilyName>Tindall</FamilyName>
                </AuthorName>
              </Author>
            </TocChapter>
            <TocChapter>
              <TocEntry PageNumber="53">
                <ExternalRef>
                  <RefSource>4. Androgens and Prostate Cancer</RefSource>
                  <RefTarget Address="10.1007/978-1-60327-829-4_4" TargetType="DOI"/>
                </ExternalRef>
              </TocEntry>
              <Author>
                <AuthorName DisplayOrder="Western">
                  <GivenName>Douglas</GivenName>
                  <GivenName>K.</GivenName>
                  <FamilyName>Price</FamilyName>
                </AuthorName>
              </Author>
              <Author>
                <AuthorName DisplayOrder="Western">
                  <GivenName>Ann</GivenName>
                  <GivenName>W.</GivenName>
                  <FamilyName>Hsing</FamilyName>
                </AuthorName>
              </Author>
            </TocChapter>
            <TocChapter>
              <TocEntry PageNumber="61">
                <ExternalRef>
                  <RefSource>5. Androgen Receptor Biology in Prostate Cancer</RefSource>
                  <RefTarget Address="10.1007/978-1-60327-829-4_5" TargetType="DOI"/>
                </ExternalRef>
              </TocEntry>
              <Author>
                <AuthorName DisplayOrder="Western">
                  <GivenName>Edward</GivenName>
                  <GivenName>P.</GivenName>
                  <FamilyName>Gelmann</FamilyName>
                </AuthorName>
              </Author>
            </TocChapter>
            <TocChapter>
              <TocEntry PageNumber="71">
                <ExternalRef>
                  <RefSource>6. Androgen Receptor Antagonists</RefSource>
                  <RefTarget Address="10.1007/978-1-60327-829-4_6" TargetType="DOI"/>
                </ExternalRef>
              </TocEntry>
              <Author>
                <AuthorName DisplayOrder="Western">
                  <GivenName>Howard</GivenName>
                  <GivenName>C.</GivenName>
                  <FamilyName>Shen</FamilyName>
                </AuthorName>
              </Author>
              <Author>
                <AuthorName DisplayOrder="Western">
                  <GivenName>Mary-Ellen</GivenName>
                  <FamilyName>Taplin</FamilyName>
                </AuthorName>
              </Author>
              <Author>
                <AuthorName DisplayOrder="Western">
                  <GivenName>Steven</GivenName>
                  <GivenName>P.</GivenName>
                  <FamilyName>Balk</FamilyName>
                </AuthorName>
              </Author>
            </TocChapter>
            <TocChapter>
              <TocEntry PageNumber="83">
                <ExternalRef>
                  <RefSource>7. 5 Alpha Reductase Inhibitors in Prostate Cancer</RefSource>
                  <RefTarget Address="10.1007/978-1-60327-829-4_7" TargetType="DOI"/>
                </ExternalRef>
              </TocEntry>
              <Author>
                <AuthorName DisplayOrder="Western">
                  <GivenName>Zoran</GivenName>
                  <FamilyName>Culig</FamilyName>
                </AuthorName>
              </Author>
            </TocChapter>
            <TocChapter>
              <TocEntry PageNumber="91">
                <ExternalRef>
                  <RefSource>8. Adrenal Androgen Synthesis Inhibitor Therapies in Castration-Resistant Prostate Cancer</RefSource>
                  <RefTarget Address="10.1007/978-1-60327-829-4_8" TargetType="DOI"/>
                </ExternalRef>
              </TocEntry>
              <Author>
                <AuthorName DisplayOrder="Western">
                  <GivenName>Terence</GivenName>
                  <GivenName>W.</GivenName>
                  <FamilyName>Friedlander</FamilyName>
                </AuthorName>
              </Author>
              <Author>
                <AuthorName DisplayOrder="Western">
                  <GivenName>Charles</GivenName>
                  <GivenName>J.</GivenName>
                  <FamilyName>Ryan</FamilyName>
                </AuthorName>
              </Author>
            </TocChapter>
            <TocChapter>
              <TocEntry PageNumber="101">
                <ExternalRef>
                  <RefSource>9. Androgen Deprivation Therapy</RefSource>
                  <RefTarget Address="10.1007/978-1-60327-829-4_9" TargetType="DOI"/>
                </ExternalRef>
              </TocEntry>
              <Author>
                <AuthorName DisplayOrder="Western">
                  <GivenName>Nima</GivenName>
                  <FamilyName>Sharifi</FamilyName>
                </AuthorName>
              </Author>
            </TocChapter>
            <TocChapter>
              <TocEntry PageNumber="109">
                <ExternalRef>
                  <RefSource>10. Pharmacogenetics of the Androgen Metabolic Pathway</RefSource>
                  <RefTarget Address="10.1007/978-1-60327-829-4_10" TargetType="DOI"/>
                </ExternalRef>
              </TocEntry>
              <Author>
                <AuthorName DisplayOrder="Western">
                  <GivenName>Francine</GivenName>
                  <GivenName>Zanchetta</GivenName>
                  <GivenName>Coelho</GivenName>
                  <FamilyName>Marques</FamilyName>
                </AuthorName>
              </Author>
              <Author>
                <AuthorName DisplayOrder="Western">
                  <GivenName>Juergen</GivenName>
                  <GivenName>K.</GivenName>
                  <GivenName>V.</GivenName>
                  <FamilyName>Reichardt</FamilyName>
                </AuthorName>
              </Author>
            </TocChapter>
          </TocPart>
          <TocPart>
            <TocEntry>Part II. Chemotherapy</TocEntry>
            <TocChapter>
              <TocEntry PageNumber="125">
                <ExternalRef>
                  <RefSource>11. Mitoxantrone</RefSource>
                  <RefTarget Address="10.1007/978-1-60327-829-4_11" TargetType="DOI"/>
                </ExternalRef>
              </TocEntry>
              <Author>
                <AuthorName DisplayOrder="Western">
                  <GivenName>Patricia</GivenName>
                  <FamilyName>Halterman</FamilyName>
                </AuthorName>
              </Author>
              <Author>
                <AuthorName DisplayOrder="Western">
                  <GivenName>Nicholas</GivenName>
                  <GivenName>J.</GivenName>
                  <FamilyName>Vogelzang</FamilyName>
                </AuthorName>
              </Author>
              <Author>
                <AuthorName DisplayOrder="Western">
                  <GivenName>Alireza</GivenName>
                  <FamilyName>Farabishahadel</FamilyName>
                </AuthorName>
              </Author>
              <Author>
                <AuthorName DisplayOrder="Western">
                  <GivenName>Oscar</GivenName>
                  <GivenName>B.</GivenName>
                  <FamilyName>Goodman</FamilyName>
                  <Suffix>Jr.</Suffix>
                </AuthorName>
              </Author>
            </TocChapter>
            <TocChapter>
              <TocEntry PageNumber="133">
                <ExternalRef>
                  <RefSource>12. Docetaxel</RefSource>
                  <RefTarget Address="10.1007/978-1-60327-829-4_12" TargetType="DOI"/>
                </ExternalRef>
              </TocEntry>
              <Author>
                <AuthorName DisplayOrder="Western">
                  <GivenName>Courtney</GivenName>
                  <GivenName>K.</GivenName>
                  <FamilyName>Phillips</FamilyName>
                </AuthorName>
              </Author>
              <Author>
                <AuthorName DisplayOrder="Western">
                  <GivenName>Daniel</GivenName>
                  <GivenName>P.</GivenName>
                  <FamilyName>Petrylak</FamilyName>
                </AuthorName>
              </Author>
            </TocChapter>
            <TocChapter>
              <TocEntry PageNumber="147">
                <ExternalRef>
                  <RefSource>13. Beyond Docetaxel : Emerging Agents in the Treatment of Advanced Prostate Cancer</RefSource>
                  <RefTarget Address="10.1007/978-1-60327-829-4_13" TargetType="DOI"/>
                </ExternalRef>
              </TocEntry>
              <Author>
                <AuthorName DisplayOrder="Western">
                  <GivenName>Jonathan</GivenName>
                  <FamilyName>Rosenberg</FamilyName>
                </AuthorName>
              </Author>
            </TocChapter>
            <TocChapter>
              <TocEntry PageNumber="153">
                <ExternalRef>
                  <RefSource>14. Platinum Agents in Prostate Cancer</RefSource>
                  <RefTarget Address="10.1007/978-1-60327-829-4_14" TargetType="DOI"/>
                </ExternalRef>
              </TocEntry>
              <Author>
                <AuthorName DisplayOrder="Western">
                  <GivenName>Ashley</GivenName>
                  <FamilyName>Brick</FamilyName>
                </AuthorName>
              </Author>
              <Author>
                <AuthorName DisplayOrder="Western">
                  <GivenName>Junyang</GivenName>
                  <FamilyName>Niu</FamilyName>
                </AuthorName>
              </Author>
              <Author>
                <AuthorName DisplayOrder="Western">
                  <GivenName>Jiaoti</GivenName>
                  <FamilyName>Huang</FamilyName>
                </AuthorName>
              </Author>
              <Author>
                <AuthorName DisplayOrder="Western">
                  <GivenName>William</GivenName>
                  <GivenName>K.</GivenName>
                  <FamilyName>Oh</FamilyName>
                </AuthorName>
              </Author>
            </TocChapter>
            <TocChapter>
              <TocEntry PageNumber="163">
                <ExternalRef>
                  <RefSource>15. Clinical Pharmacology and Pharmacogenetics of Chemotherapy in Prostate Cancer</RefSource>
                  <RefTarget Address="10.1007/978-1-60327-829-4_15" TargetType="DOI"/>
                </ExternalRef>
              </TocEntry>
              <Author>
                <AuthorName DisplayOrder="Western">
                  <GivenName>Tristan</GivenName>
                  <GivenName>M.</GivenName>
                  <FamilyName>Sissung</FamilyName>
                </AuthorName>
              </Author>
              <Author>
                <AuthorName DisplayOrder="Western">
                  <GivenName>William</GivenName>
                  <GivenName>D.</GivenName>
                  <FamilyName>Figg</FamilyName>
                </AuthorName>
              </Author>
            </TocChapter>
            <TocChapter>
              <TocEntry PageNumber="179">
                <ExternalRef>
                  <RefSource>16. Microtubule Targeting Agents</RefSource>
                  <RefTarget Address="10.1007/978-1-60327-829-4_16" TargetType="DOI"/>
                </ExternalRef>
              </TocEntry>
              <Author>
                <AuthorName DisplayOrder="Western">
                  <GivenName>Antonio</GivenName>
                  <GivenName>Tito</GivenName>
                  <FamilyName>Fojo</FamilyName>
                </AuthorName>
              </Author>
              <Author>
                <AuthorName DisplayOrder="Western">
                  <GivenName>David</GivenName>
                  <GivenName>E.</GivenName>
                  <FamilyName>Adelberg</FamilyName>
                </AuthorName>
              </Author>
            </TocChapter>
          </TocPart>
          <TocPart>
            <TocEntry>Part III. Angiogenesis</TocEntry>
            <TocChapter>
              <TocEntry PageNumber="197">
                <ExternalRef>
                  <RefSource>17. Principles of Antiangiogenic Therapy</RefSource>
                  <RefTarget Address="10.1007/978-1-60327-829-4_17" TargetType="DOI"/>
                </ExternalRef>
              </TocEntry>
              <Author>
                <AuthorName DisplayOrder="Western">
                  <GivenName>Cindy</GivenName>
                  <GivenName>H.</GivenName>
                  <FamilyName>Chau</FamilyName>
                </AuthorName>
              </Author>
              <Author>
                <AuthorName DisplayOrder="Western">
                  <GivenName>William</GivenName>
                  <GivenName>D.</GivenName>
                  <FamilyName>Figg</FamilyName>
                </AuthorName>
              </Author>
            </TocChapter>
            <TocChapter>
              <TocEntry PageNumber="207">
                <ExternalRef>
                  <RefSource>18. Bevacizumab in Advanced Prostate Cancer</RefSource>
                  <RefTarget Address="10.1007/978-1-60327-829-4_18" TargetType="DOI"/>
                </ExternalRef>
              </TocEntry>
              <Author>
                <AuthorName DisplayOrder="Western">
                  <GivenName>Aymen</GivenName>
                  <GivenName>A.</GivenName>
                  <FamilyName>Elfiky</FamilyName>
                </AuthorName>
              </Author>
              <Author>
                <AuthorName DisplayOrder="Western">
                  <GivenName>William</GivenName>
                  <GivenName>Kevin</GivenName>
                  <FamilyName>Kelly</FamilyName>
                </AuthorName>
              </Author>
            </TocChapter>
            <TocChapter>
              <TocEntry PageNumber="215">
                <ExternalRef>
                  <RefSource>19. Thalidomide and Analogs</RefSource>
                  <RefTarget Address="10.1007/978-1-60327-829-4_19" TargetType="DOI"/>
                </ExternalRef>
              </TocEntry>
              <Author>
                <AuthorName DisplayOrder="Western">
                  <GivenName>Erin</GivenName>
                  <GivenName>R.</GivenName>
                  <FamilyName>Gardner</FamilyName>
                </AuthorName>
              </Author>
              <Author>
                <AuthorName DisplayOrder="Western">
                  <GivenName>Giuseppe</GivenName>
                  <Particle>Di</Particle>
                  <FamilyName>Lorenzo</FamilyName>
                </AuthorName>
              </Author>
              <Author>
                <AuthorName DisplayOrder="Western">
                  <GivenName>William</GivenName>
                  <GivenName>D.</GivenName>
                  <FamilyName>Figg</FamilyName>
                </AuthorName>
              </Author>
            </TocChapter>
            <TocChapter>
              <TocEntry PageNumber="225">
                <ExternalRef>
                  <RefSource>20. Investigational Angiogenesis Inhibitors</RefSource>
                  <RefTarget Address="10.1007/978-1-60327-829-4_20" TargetType="DOI"/>
                </ExternalRef>
              </TocEntry>
              <Author>
                <AuthorName DisplayOrder="Western">
                  <GivenName>Jeanny</GivenName>
                  <GivenName>B.</GivenName>
                  <FamilyName>Aragon-Ching</FamilyName>
                </AuthorName>
              </Author>
              <Author>
                <AuthorName DisplayOrder="Western">
                  <GivenName>William</GivenName>
                  <FamilyName>Dahut</FamilyName>
                </AuthorName>
              </Author>
            </TocChapter>
            <TocChapter>
              <TocEntry PageNumber="233">
                <ExternalRef>
                  <RefSource>21. Pharmacogenetics of Angiogenesis</RefSource>
                  <RefTarget Address="10.1007/978-1-60327-829-4_21" TargetType="DOI"/>
                </ExternalRef>
              </TocEntry>
              <Author>
                <AuthorName DisplayOrder="Western">
                  <GivenName>Guido</GivenName>
                  <FamilyName>Bocci</FamilyName>
                </AuthorName>
              </Author>
              <Author>
                <AuthorName DisplayOrder="Western">
                  <GivenName>Giuseppe</GivenName>
                  <Particle>Di</Particle>
                  <FamilyName>Pasqualetti</FamilyName>
                </AuthorName>
              </Author>
              <Author>
                <AuthorName DisplayOrder="Western">
                  <GivenName>Antonello</GivenName>
                  <Particle>Di</Particle>
                  <FamilyName>Paolo</FamilyName>
                </AuthorName>
              </Author>
              <Author>
                <AuthorName DisplayOrder="Western">
                  <GivenName>Francesco</GivenName>
                  <FamilyName>Crea</FamilyName>
                </AuthorName>
              </Author>
              <Author>
                <AuthorName DisplayOrder="Western">
                  <GivenName>Mario</GivenName>
                  <Particle>Del</Particle>
                  <FamilyName>Tacca</FamilyName>
                </AuthorName>
              </Author>
              <Author>
                <AuthorName DisplayOrder="Western">
                  <GivenName>Romano</GivenName>
                  <FamilyName>Danesi</FamilyName>
                </AuthorName>
              </Author>
            </TocChapter>
          </TocPart>
          <TocPart>
            <TocEntry>Part IV. Bone Metastasis</TocEntry>
            <TocChapter>
              <TocEntry PageNumber="245">
                <ExternalRef>
                  <RefSource>22. Pathophysiology of Prostate Cancer Bone Metastases</RefSource>
                  <RefTarget Address="10.1007/978-1-60327-829-4_22" TargetType="DOI"/>
                </ExternalRef>
              </TocEntry>
              <Author>
                <AuthorName DisplayOrder="Western">
                  <GivenName>Evan</GivenName>
                  <GivenName>T.</GivenName>
                  <FamilyName>Keller</FamilyName>
                </AuthorName>
              </Author>
              <Author>
                <AuthorName DisplayOrder="Western">
                  <GivenName>Christopher</GivenName>
                  <GivenName>L.</GivenName>
                  <FamilyName>Hall</FamilyName>
                </AuthorName>
              </Author>
            </TocChapter>
            <TocChapter>
              <TocEntry PageNumber="255">
                <ExternalRef>
                  <RefSource>23. Radiopharmaceuticals</RefSource>
                  <RefTarget Address="10.1007/978-1-60327-829-4_23" TargetType="DOI"/>
                </ExternalRef>
              </TocEntry>
              <Author>
                <AuthorName DisplayOrder="Western">
                  <GivenName>Oliver</GivenName>
                  <FamilyName>Sartor</FamilyName>
                </AuthorName>
              </Author>
              <Author>
                <AuthorName DisplayOrder="Western">
                  <GivenName>Damerla</GivenName>
                  <GivenName>R.</GivenName>
                  <FamilyName>Venugopal</FamilyName>
                </AuthorName>
              </Author>
            </TocChapter>
            <TocChapter>
              <TocEntry PageNumber="267">
                <ExternalRef>
                  <RefSource>24. Bisphosphonates for Prevention and Treatment of Bone Metastases</RefSource>
                  <RefTarget Address="10.1007/978-1-60327-829-4_24" TargetType="DOI"/>
                </ExternalRef>
              </TocEntry>
              <Author>
                <AuthorName DisplayOrder="Western">
                  <GivenName>Philip</GivenName>
                  <GivenName>J.</GivenName>
                  <FamilyName>Saylor</FamilyName>
                </AuthorName>
              </Author>
              <Author>
                <AuthorName DisplayOrder="Western">
                  <GivenName>Matthew</GivenName>
                  <GivenName>R.</GivenName>
                  <FamilyName>Smith</FamilyName>
                </AuthorName>
              </Author>
            </TocChapter>
            <TocChapter>
              <TocEntry PageNumber="277">
                <ExternalRef>
                  <RefSource>25. Endothelin Receptors as Therapeutic Targets in Castrate-Resistant Prostate Cancer</RefSource>
                  <RefTarget Address="10.1007/978-1-60327-829-4_25" TargetType="DOI"/>
                </ExternalRef>
              </TocEntry>
              <Author>
                <AuthorName DisplayOrder="Western">
                  <GivenName>Joel</GivenName>
                  <GivenName>B.</GivenName>
                  <FamilyName>Nelson</FamilyName>
                </AuthorName>
              </Author>
            </TocChapter>
            <TocChapter>
              <TocEntry PageNumber="287">
                <ExternalRef>
                  <RefSource>26. Calcitriol and Vitamin D Analogs</RefSource>
                  <RefTarget Address="10.1007/978-1-60327-829-4_26" TargetType="DOI"/>
                </ExternalRef>
              </TocEntry>
              <Author>
                <AuthorName DisplayOrder="Western">
                  <GivenName>Ana</GivenName>
                  <GivenName>R.</GivenName>
                  <FamilyName>Jensen</FamilyName>
                </AuthorName>
              </Author>
              <Author>
                <AuthorName DisplayOrder="Western">
                  <GivenName>Russell</GivenName>
                  <GivenName>Z.</GivenName>
                  <FamilyName>Szmulewitz</FamilyName>
                </AuthorName>
              </Author>
              <Author>
                <AuthorName DisplayOrder="Western">
                  <GivenName>Tomasz</GivenName>
                  <GivenName>M.</GivenName>
                  <FamilyName>Beer</FamilyName>
                </AuthorName>
              </Author>
              <Author>
                <AuthorName DisplayOrder="Western">
                  <GivenName>Edwin</GivenName>
                  <GivenName>M.</GivenName>
                  <FamilyName>Posadas</FamilyName>
                </AuthorName>
              </Author>
            </TocChapter>
          </TocPart>
          <TocPart>
            <TocEntry>Part V. Immunotherapy</TocEntry>
            <TocChapter>
              <TocEntry PageNumber="305">
                <ExternalRef>
                  <RefSource>27. Cancer Immunology, Immunotherapeutics, and Vaccine Approaches</RefSource>
                  <RefTarget Address="10.1007/978-1-60327-829-4_27" TargetType="DOI"/>
                </ExternalRef>
              </TocEntry>
              <Author>
                <AuthorName DisplayOrder="Western">
                  <GivenName>Ravi</GivenName>
                  <GivenName>A.</GivenName>
                  <FamilyName>Madan</FamilyName>
                </AuthorName>
              </Author>
              <Author>
                <AuthorName DisplayOrder="Western">
                  <GivenName>James</GivenName>
                  <GivenName>L.</GivenName>
                  <FamilyName>Gulley</FamilyName>
                </AuthorName>
              </Author>
              <Author>
                <AuthorName DisplayOrder="Western">
                  <GivenName>Jackie</GivenName>
                  <FamilyName>Celestin</FamilyName>
                </AuthorName>
              </Author>
              <Author>
                <AuthorName DisplayOrder="Western">
                  <GivenName>Philip</GivenName>
                  <GivenName>M.</GivenName>
                  <FamilyName>Arlen</FamilyName>
                </AuthorName>
              </Author>
              <Author>
                <AuthorName DisplayOrder="Western">
                  <GivenName>Jeffrey</GivenName>
                  <FamilyName>Schlom</FamilyName>
                </AuthorName>
              </Author>
            </TocChapter>
            <TocChapter>
              <TocEntry PageNumber="321">
                <ExternalRef>
                  <RefSource>28. Sipuleucel-T ( APC8015 ): Active Cellular Immunotherapy for Advanced Metastatic Castrate-Resistant Prostate Cancer</RefSource>
                  <RefTarget Address="10.1007/978-1-60327-829-4_28" TargetType="DOI"/>
                </ExternalRef>
              </TocEntry>
              <Author>
                <AuthorName DisplayOrder="Western">
                  <GivenName>Celestia</GivenName>
                  <GivenName>S.</GivenName>
                  <FamilyName>Higano</FamilyName>
                </AuthorName>
              </Author>
              <Author>
                <AuthorName DisplayOrder="Western">
                  <GivenName>Mark</GivenName>
                  <GivenName>W.</GivenName>
                  <FamilyName>Frohlich</FamilyName>
                </AuthorName>
              </Author>
            </TocChapter>
            <TocChapter>
              <TocEntry PageNumber="329">
                <ExternalRef>
                  <RefSource>29 GM-CSF Gene-Transduced Prostate Cancer Vaccines: GVAX</RefSource>
                  <RefTarget Address="10.1007/978-1-60327-829-4_29" TargetType="DOI"/>
                </ExternalRef>
              </TocEntry>
              <Author>
                <AuthorName DisplayOrder="Western">
                  <GivenName>Lalit</GivenName>
                  <GivenName>R.</GivenName>
                  <FamilyName>Patel</FamilyName>
                </AuthorName>
              </Author>
              <Author>
                <AuthorName DisplayOrder="Western">
                  <GivenName>Jonathan</GivenName>
                  <GivenName>W.</GivenName>
                  <FamilyName>Simons</FamilyName>
                </AuthorName>
              </Author>
            </TocChapter>
            <TocChapter>
              <TocEntry PageNumber="343">
                <ExternalRef>
                  <RefSource>30. CTLA-4 Blockade for Prostate Cancer Treatment</RefSource>
                  <RefTarget Address="10.1007/978-1-60327-829-4_30" TargetType="DOI"/>
                </ExternalRef>
              </TocEntry>
              <Author>
                <AuthorName DisplayOrder="Western">
                  <GivenName>Andrea</GivenName>
                  <GivenName>L.</GivenName>
                  <FamilyName>Harzstark</FamilyName>
                </AuthorName>
              </Author>
              <Author>
                <AuthorName DisplayOrder="Western">
                  <GivenName>Lawrence</GivenName>
                  <FamilyName>Fong</FamilyName>
                </AuthorName>
              </Author>
            </TocChapter>
          </TocPart>
          <TocPart>
            <TocEntry>Part VI. Prevention</TocEntry>
            <TocChapter>
              <TocEntry PageNumber="351">
                <ExternalRef>
                  <RefSource>31. Prostate Cancer Chemoprevention Strategies</RefSource>
                  <RefTarget Address="10.1007/978-1-60327-829-4_31" TargetType="DOI"/>
                </ExternalRef>
              </TocEntry>
              <Author>
                <AuthorName DisplayOrder="Western">
                  <GivenName>Howard</GivenName>
                  <GivenName>L.</GivenName>
                  <FamilyName>Parnes</FamilyName>
                </AuthorName>
              </Author>
              <Author>
                <AuthorName DisplayOrder="Western">
                  <GivenName>Margaret</GivenName>
                  <GivenName>G.</GivenName>
                  <FamilyName>House</FamilyName>
                </AuthorName>
              </Author>
              <Author>
                <AuthorName DisplayOrder="Western">
                  <GivenName>Joseph</GivenName>
                  <GivenName>A.</GivenName>
                  <FamilyName>Tangrea</FamilyName>
                </AuthorName>
              </Author>
            </TocChapter>
            <TocChapter>
              <TocEntry PageNumber="363">
                <ExternalRef>
                  <RefSource>32. Diet and Prostate Cancer Incidence, Recurrence, and Progression Risk</RefSource>
                  <RefTarget Address="10.1007/978-1-60327-829-4_32" TargetType="DOI"/>
                </ExternalRef>
              </TocEntry>
              <Author>
                <AuthorName DisplayOrder="Western">
                  <GivenName>June</GivenName>
                  <GivenName>M.</GivenName>
                  <FamilyName>Chan</FamilyName>
                </AuthorName>
              </Author>
              <Author>
                <AuthorName DisplayOrder="Western">
                  <GivenName>Erin</GivenName>
                  <GivenName>L.</GivenName>
                  <FamilyName>Richman</FamilyName>
                </AuthorName>
              </Author>
            </TocChapter>
            <TocChapter>
              <TocEntry PageNumber="375">
                <ExternalRef>
                  <RefSource>33. Inflammation as a Target in Prostate Cancer</RefSource>
                  <RefTarget Address="10.1007/978-1-60327-829-4_33" TargetType="DOI"/>
                </ExternalRef>
              </TocEntry>
              <Author>
                <AuthorName DisplayOrder="Western">
                  <GivenName>Marshall</GivenName>
                  <GivenName>Scott</GivenName>
                  <FamilyName>Lucia</FamilyName>
                </AuthorName>
              </Author>
              <Author>
                <AuthorName DisplayOrder="Western">
                  <GivenName>James</GivenName>
                  <GivenName>R.</GivenName>
                  <FamilyName>Lambert</FamilyName>
                </AuthorName>
              </Author>
              <Author>
                <AuthorName DisplayOrder="Western">
                  <GivenName>Elizabeth</GivenName>
                  <GivenName>A.</GivenName>
                  <FamilyName>Platz</FamilyName>
                </AuthorName>
              </Author>
              <Author>
                <AuthorName DisplayOrder="Western">
                  <GivenName>Angelo</GivenName>
                  <GivenName>M.</GivenName>
                  <Particle>De</Particle>
                  <FamilyName>Marzo</FamilyName>
                </AuthorName>
              </Author>
            </TocChapter>
          </TocPart>
          <TocPart>
            <TocEntry>Drug Development</TocEntry>
            <TocChapter>
              <TocEntry PageNumber="389">
                <ExternalRef>
                  <RefSource>34. Challenges for the Development of New Agents in Prostate Cancer</RefSource>
                  <RefTarget Address="10.1007/978-1-60327-829-4_34" TargetType="DOI"/>
                </ExternalRef>
              </TocEntry>
              <Author>
                <AuthorName DisplayOrder="Western">
                  <GivenName>Ajjai</GivenName>
                  <GivenName>S.</GivenName>
                  <FamilyName>Alva</FamilyName>
                </AuthorName>
              </Author>
              <Author>
                <AuthorName DisplayOrder="Western">
                  <GivenName>Deborah</GivenName>
                  <GivenName>A.</GivenName>
                  <FamilyName>Bradley</FamilyName>
                </AuthorName>
              </Author>
              <Author>
                <AuthorName DisplayOrder="Western">
                  <GivenName>Maha</GivenName>
                  <FamilyName>Hussain</FamilyName>
                </AuthorName>
              </Author>
            </TocChapter>
            <TocChapter>
              <TocEntry PageNumber="399">
                <ExternalRef>
                  <RefSource>35. FDA Approval of Prostate Cancer Treatments</RefSource>
                  <RefTarget Address="10.1007/978-1-60327-829-4_35" TargetType="DOI"/>
                </ExternalRef>
              </TocEntry>
              <Author>
                <AuthorName DisplayOrder="Western">
                  <GivenName>Yang-Min</GivenName>
                  <FamilyName>Ning</FamilyName>
                </AuthorName>
              </Author>
              <Author>
                <AuthorName DisplayOrder="Western">
                  <GivenName>Ramzi</GivenName>
                  <GivenName>N.</GivenName>
                  <FamilyName>Dagher</FamilyName>
                </AuthorName>
              </Author>
              <Author>
                <AuthorName DisplayOrder="Western">
                  <GivenName>Richard</GivenName>
                  <FamilyName>Pazdur</FamilyName>
                </AuthorName>
              </Author>
            </TocChapter>
            <TocChapter>
              <TocEntry PageNumber="407">
                <ExternalRef>
                  <RefSource>36. Applications of Proteomics in Prostate Cancer</RefSource>
                  <RefTarget Address="10.1007/978-1-60327-829-4_36" TargetType="DOI"/>
                </ExternalRef>
              </TocEntry>
              <Author>
                <AuthorName DisplayOrder="Western">
                  <GivenName>Mitchell</GivenName>
                  <FamilyName>Gross</FamilyName>
                </AuthorName>
              </Author>
              <Author>
                <AuthorName DisplayOrder="Western">
                  <GivenName>Edward</GivenName>
                  <GivenName>Macrohon</GivenName>
                  <FamilyName>Nepomuceno</FamilyName>
                </AuthorName>
              </Author>
              <Author>
                <AuthorName DisplayOrder="Western">
                  <GivenName>David</GivenName>
                  <GivenName>B.</GivenName>
                  <FamilyName>Agus</FamilyName>
                </AuthorName>
              </Author>
            </TocChapter>
            <TocChapter>
              <TocEntry PageNumber="E1">
                <ExternalRef>
                  <RefSource>Erratum</RefSource>
                  <RefTarget Address="10.1007/978-1-60327-829-4_37" TargetType="DOI"/>
                </ExternalRef>
              </TocEntry>
            </TocChapter>
          </TocPart>
          <TocBack PageNumber="419">Index</TocBack>
        </Toc>
        <Loc>
          <Heading>Contributors</Heading>
          <LocEntry>
            <AuthorGroup>
              <Author AffiliationIDS="Aff3">
                <AuthorName DisplayOrder="Western">
                  <GivenName>David</GivenName>
                  <GivenName>E.</GivenName>
                  <FamilyName>Adelberg</FamilyName>
                </AuthorName>
              </Author>
              <Affiliation ID="Aff3">
                <OrgDivision>Medical Oncology Branch</OrgDivision>
                <OrgName>National Cancer Institute</OrgName>
                <OrgAddress>
                  <City>Bethesda</City>
                  <State>MD</State>
                  <Country>USA</Country>
                </OrgAddress>
              </Affiliation>
            </AuthorGroup>
          </LocEntry>
          <LocEntry>
            <AuthorGroup>
              <Author AffiliationIDS="Aff4">
                <AuthorName DisplayOrder="Western">
                  <GivenName>David</GivenName>
                  <GivenName>B.</GivenName>
                  <FamilyName>Agus</FamilyName>
                </AuthorName>
              </Author>
              <Affiliation ID="Aff4">
                <OrgDivision>USC, Westside Prostate Cancer Center</OrgDivision>
                <OrgName>Keck School of Medicine of USC</OrgName>
                <OrgAddress>
                  <City>Beverly Hills</City>
                  <State>CA</State>
                  <Country>USA</Country>
                </OrgAddress>
              </Affiliation>
            </AuthorGroup>
          </LocEntry>
          <LocEntry>
            <AuthorGroup>
              <Author AffiliationIDS="Aff5">
                <AuthorName DisplayOrder="Western">
                  <GivenName>Ajjai</GivenName>
                  <GivenName>S.</GivenName>
                  <FamilyName>Alva</FamilyName>
                </AuthorName>
              </Author>
              <Affiliation ID="Aff5">
                <OrgDivision>Doctor, Hematology/Oncology Department</OrgDivision>
                <OrgName>University of Michigan</OrgName>
                <OrgAddress>
                  <City>Ann Arbor</City>
                  <State>MI</State>
                  <Country>USA</Country>
                </OrgAddress>
              </Affiliation>
            </AuthorGroup>
          </LocEntry>
          <LocEntry>
            <AuthorGroup>
              <Author AffiliationIDS="Aff6">
                <AuthorName DisplayOrder="Western">
                  <GivenName>Jeanny</GivenName>
                  <GivenName>B.</GivenName>
                  <FamilyName>Aragon-Ching</FamilyName>
                </AuthorName>
              </Author>
              <Affiliation ID="Aff6">
                <OrgDivision>Department of Medicine</OrgDivision>
                <OrgName>George Washington University</OrgName>
                <OrgAddress>
                  <City>Washington</City>
                  <State>DC</State>
                  <Country>USA</Country>
                </OrgAddress>
              </Affiliation>
            </AuthorGroup>
          </LocEntry>
          <LocEntry>
            <AuthorGroup>
              <Author AffiliationIDS="Aff7">
                <AuthorName DisplayOrder="Western">
                  <GivenName>Philip</GivenName>
                  <GivenName>M.</GivenName>
                  <FamilyName>Arlen</FamilyName>
                </AuthorName>
                <Role>Attending Physician</Role>
              </Author>
              <Affiliation ID="Aff7">
                <OrgDivision>Medical Oncology Branch</OrgDivision>
                <OrgName>National Cancer Institute, National Institutes of Health</OrgName>
                <OrgAddress>
                  <City>Bethesda</City>
                  <State>MD</State>
                  <Country>USA</Country>
                </OrgAddress>
              </Affiliation>
            </AuthorGroup>
          </LocEntry>
          <LocEntry>
            <AuthorGroup>
              <Author AffiliationIDS="Aff8">
                <AuthorName DisplayOrder="Western">
                  <GivenName>Steven</GivenName>
                  <GivenName>P.</GivenName>
                  <FamilyName>Balk</FamilyName>
                </AuthorName>
              </Author>
              <Affiliation ID="Aff8">
                <OrgDivision>Department of Medicine, Beth Israel Deaconess Medical Center</OrgDivision>
                <OrgName>Harvard Medical School</OrgName>
                <OrgAddress>
                  <City>Boston</City>
                  <State>MA 02215</State>
                  <Country>USA</Country>
                </OrgAddress>
              </Affiliation>
            </AuthorGroup>
          </LocEntry>
          <LocEntry>
            <AuthorGroup>
              <Author AffiliationIDS="Aff9">
                <AuthorName DisplayOrder="Western">
                  <GivenName>Tomasz</GivenName>
                  <GivenName>M.</GivenName>
                  <FamilyName>Beer</FamilyName>
                </AuthorName>
                <Role>Associate Professor of Medicine, Grover C. Bagby Endowed Chair for Prostate Cancer Research</Role>
              </Author>
              <Affiliation ID="Aff9">
                <OrgName>Medicine/Hematology and Medical Oncology, Oregon Health &amp; Science University</OrgName>
                <OrgAddress>
                  <City>Portland</City>
                  <State>OR</State>
                  <Country>USA</Country>
                </OrgAddress>
              </Affiliation>
            </AuthorGroup>
          </LocEntry>
          <LocEntry>
            <AuthorGroup>
              <Author AffiliationIDS="Aff10">
                <AuthorName DisplayOrder="Western">
                  <GivenName>Norman</GivenName>
                  <GivenName>L.</GivenName>
                  <FamilyName>Block</FamilyName>
                </AuthorName>
                <Role>Clinical Director of the Endocrine, Polypeptide, and Cancer Institute, Pathology, Urology, Oncology</Role>
              </Author>
              <Affiliation ID="Aff10">
                <OrgDivision>Miami Veterans Affairs Medical Center</OrgDivision>
                <OrgName>Jackson Memorial Hospital, University of Miami Hospital, University of Miami</OrgName>
                <OrgAddress>
                  <City>Miami</City>
                  <State>FL</State>
                  <Country>USA</Country>
                </OrgAddress>
              </Affiliation>
            </AuthorGroup>
          </LocEntry>
          <LocEntry>
            <AuthorGroup>
              <Author AffiliationIDS="Aff11">
                <AuthorName DisplayOrder="Western">
                  <GivenName>Guido</GivenName>
                  <FamilyName>Bocci</FamilyName>
                </AuthorName>
                <Role>Assistant Professor</Role>
              </Author>
              <Affiliation ID="Aff11">
                <OrgDivision>Division of Pharmacology and Chemotherapy, Department of Internal Medicine</OrgDivision>
                <OrgName>University of Pisa</OrgName>
                <OrgAddress>
                  <City>Pisa</City>
                  <Country>Italy</Country>
                </OrgAddress>
              </Affiliation>
            </AuthorGroup>
          </LocEntry>
          <LocEntry>
            <AuthorGroup>
              <Author AffiliationIDS="Aff12">
                <AuthorName DisplayOrder="Western">
                  <GivenName>Deborah</GivenName>
                  <GivenName>A.</GivenName>
                  <FamilyName>Bradley</FamilyName>
                </AuthorName>
                <Role>Assistant Professor of Medicine</Role>
              </Author>
              <Affiliation ID="Aff12">
                <OrgDivision>Department of Internal Medicine</OrgDivision>
                <OrgName>University of Michigan</OrgName>
                <OrgAddress>
                  <City>Ann Arbor</City>
                  <State>MI</State>
                  <Country>USA</Country>
                </OrgAddress>
              </Affiliation>
            </AuthorGroup>
          </LocEntry>
          <LocEntry>
            <AuthorGroup>
              <Author AffiliationIDS="Aff13">
                <AuthorName DisplayOrder="Western">
                  <GivenName>Ashley</GivenName>
                  <FamilyName>Brick</FamilyName>
                </AuthorName>
                <Role>Clinical Research Coordinator</Role>
              </Author>
              <Affiliation ID="Aff13">
                <OrgDivision>Genitourinary Oncology</OrgDivision>
                <OrgName>Dana-Farber Cancer Institute</OrgName>
                <OrgAddress>
                  <City>Boston</City>
                  <State>MA</State>
                  <Country>USA</Country>
                </OrgAddress>
              </Affiliation>
            </AuthorGroup>
          </LocEntry>
          <LocEntry>
            <AuthorGroup>
              <Author AffiliationIDS="Aff14">
                <AuthorName DisplayOrder="Western">
                  <GivenName>Jackie</GivenName>
                  <FamilyName>Celestin</FamilyName>
                </AuthorName>
              </Author>
              <Affiliation ID="Aff14">
                <OrgDivision>Internal Medicine</OrgDivision>
                <OrgName>University of Connecticut</OrgName>
                <OrgAddress>
                  <City>Farmington</City>
                  <State>CT</State>
                  <Country>USA</Country>
                </OrgAddress>
              </Affiliation>
            </AuthorGroup>
          </LocEntry>
          <LocEntry>
            <AuthorGroup>
              <Author AffiliationIDS="Aff15">
                <AuthorName DisplayOrder="Western">
                  <GivenName>June</GivenName>
                  <GivenName>M.</GivenName>
                  <FamilyName>Chan</FamilyName>
                </AuthorName>
              </Author>
              <Affiliation ID="Aff15">
                <OrgDivision>Epidemiology and Biostatistics, Urology</OrgDivision>
                <OrgName>University of California</OrgName>
                <OrgAddress>
                  <City>San Francisco</City>
                  <State>CA</State>
                  <Country>USA</Country>
                </OrgAddress>
              </Affiliation>
            </AuthorGroup>
          </LocEntry>
          <LocEntry>
            <AuthorGroup>
              <Author AffiliationIDS="Aff16">
                <AuthorName DisplayOrder="Western">
                  <GivenName>Michael</GivenName>
                  <GivenName>E.</GivenName>
                  <FamilyName>Cox</FamilyName>
                </AuthorName>
                <Role>Associate Professor</Role>
              </Author>
              <Affiliation ID="Aff16">
                <OrgDivision>UBC Department of Urologic Sciences, The Vancouver Prostate Centre</OrgDivision>
                <OrgName>Vancouver General Hospital, University of British Columbia</OrgName>
                <OrgAddress>
                  <City>Vancouver</City>
                  <State>BC</State>
                  <Country>Canada</Country>
                </OrgAddress>
              </Affiliation>
            </AuthorGroup>
          </LocEntry>
          <LocEntry>
            <AuthorGroup>
              <Author AffiliationIDS="Aff17">
                <AuthorName DisplayOrder="Western">
                  <GivenName>Francesco</GivenName>
                  <FamilyName>Crea</FamilyName>
                </AuthorName>
                <Role>Student</Role>
              </Author>
              <Affiliation ID="Aff17">
                <OrgDivision>Division of Pharmacology and Chemotherapy, Department of Internal Medicine</OrgDivision>
                <OrgName>University of Pisa</OrgName>
                <OrgAddress>
                  <City>Pisa</City>
                  <Country>Italy</Country>
                </OrgAddress>
              </Affiliation>
            </AuthorGroup>
          </LocEntry>
          <LocEntry>
            <AuthorGroup>
              <Author AffiliationIDS="Aff18">
                <AuthorName DisplayOrder="Western">
                  <GivenName>Zoran</GivenName>
                  <FamilyName>Culig</FamilyName>
                </AuthorName>
              </Author>
              <Affiliation ID="Aff18">
                <OrgDivision>Department of Urology</OrgDivision>
                <OrgName>Innsbruck Medical University</OrgName>
                <OrgAddress>
                  <City>Innsbruck</City>
                  <Country>Austria</Country>
                </OrgAddress>
              </Affiliation>
            </AuthorGroup>
          </LocEntry>
          <LocEntry>
            <AuthorGroup>
              <Author AffiliationIDS="Aff19">
                <AuthorName DisplayOrder="Western">
                  <GivenName>Ramzi</GivenName>
                  <GivenName>N.</GivenName>
                  <FamilyName>Dagher</FamilyName>
                </AuthorName>
              </Author>
              <Affiliation ID="Aff19">
                <OrgDivision>VP Worldwide Regulatory Strategy, Global Research and Development</OrgDivision>
                <OrgName>Pfizer, Inc.</OrgName>
                <OrgAddress>
                  <City>New London</City>
                  <State>CT</State>
                  <Country>USA</Country>
                </OrgAddress>
              </Affiliation>
            </AuthorGroup>
          </LocEntry>
          <LocEntry>
            <AuthorGroup>
              <Author AffiliationIDS="Aff20">
                <AuthorName DisplayOrder="Western">
                  <GivenName>William</GivenName>
                  <FamilyName>Dahut</FamilyName>
                </AuthorName>
                <Role>Chief Genitourinary Research Section</Role>
              </Author>
              <Affiliation ID="Aff20">
                <OrgDivision>Medical Oncology Branch, CCR, NCI, NIH Clinical Center</OrgDivision>
                <OrgName>National Cancer Institute</OrgName>
                <OrgAddress>
                  <City>Bethesda</City>
                  <State>MD</State>
                  <Country>USA</Country>
                </OrgAddress>
              </Affiliation>
            </AuthorGroup>
          </LocEntry>
          <LocEntry>
            <AuthorGroup>
              <Author AffiliationIDS="Aff21">
                <AuthorName DisplayOrder="Western">
                  <GivenName>Romano</GivenName>
                  <FamilyName>Danesi</FamilyName>
                </AuthorName>
              </Author>
              <Affiliation ID="Aff21">
                <OrgDivision>Division of Pharmacology and Chemotherapy, Department of Internal Medicine</OrgDivision>
                <OrgName>University of Pisa</OrgName>
                <OrgAddress>
                  <City>Pisa</City>
                  <Country>Italy</Country>
                </OrgAddress>
              </Affiliation>
            </AuthorGroup>
          </LocEntry>
          <LocEntry>
            <AuthorGroup>
              <Author AffiliationIDS="Aff22">
                <AuthorName DisplayOrder="Western">
                  <GivenName>Angelo</GivenName>
                  <GivenName>M.</GivenName>
                  <Particle>De</Particle>
                  <FamilyName>Marzo</FamilyName>
                </AuthorName>
              </Author>
              <Affiliation ID="Aff22">
                <OrgDivision>Department of Pathology, Bunting Blaustein Cancer Research</OrgDivision>
                <OrgName>The Johns Hopkins University School of Medicine</OrgName>
                <OrgAddress>
                  <City>Baltimore</City>
                  <State>MD</State>
                  <Country>USA</Country>
                </OrgAddress>
              </Affiliation>
            </AuthorGroup>
          </LocEntry>
          <LocEntry>
            <AuthorGroup>
              <Author AffiliationIDS="Aff23">
                <AuthorName DisplayOrder="Western">
                  <GivenName>Mario</GivenName>
                  <Particle>Del</Particle>
                  <FamilyName>Tacca</FamilyName>
                </AuthorName>
                <Role>Full Professor</Role>
              </Author>
              <Affiliation ID="Aff23">
                <OrgDivision>Division of Pharmacology and Chemotherapy, Department of Internal Medicine</OrgDivision>
                <OrgName>University of Pisa</OrgName>
                <OrgAddress>
                  <City>Pisa</City>
                  <Country>Italy</Country>
                </OrgAddress>
              </Affiliation>
            </AuthorGroup>
          </LocEntry>
          <LocEntry>
            <AuthorGroup>
              <Author AffiliationIDS="Aff24">
                <AuthorName DisplayOrder="Western">
                  <GivenName>Giuseppe</GivenName>
                  <Particle>Di</Particle>
                  <FamilyName>Lorenzo</FamilyName>
                </AuthorName>
              </Author>
              <Affiliation ID="Aff24">
                <OrgDivision>Medical Oncology</OrgDivision>
                <OrgName>AOU Federico II</OrgName>
                <OrgAddress>
                  <City>Napoli</City>
                  <Country>Italy</Country>
                </OrgAddress>
              </Affiliation>
            </AuthorGroup>
          </LocEntry>
          <LocEntry>
            <AuthorGroup>
              <Author AffiliationIDS="Aff25">
                <AuthorName DisplayOrder="Western">
                  <GivenName>Antonello</GivenName>
                  <Particle>Di</Particle>
                  <FamilyName>Paolo</FamilyName>
                </AuthorName>
              </Author>
              <Affiliation ID="Aff25">
                <OrgDivision>Division of Pharmacology and Chemotherapy, Department of Internal Medicine</OrgDivision>
                <OrgName>University of Pisa</OrgName>
                <OrgAddress>
                  <City>Pisa</City>
                  <Country>Italy</Country>
                </OrgAddress>
              </Affiliation>
            </AuthorGroup>
          </LocEntry>
          <LocEntry>
            <AuthorGroup>
              <Author AffiliationIDS="Aff26">
                <AuthorName DisplayOrder="Western">
                  <GivenName>Aymen</GivenName>
                  <GivenName>A.</GivenName>
                  <FamilyName>Elfiky</FamilyName>
                </AuthorName>
              </Author>
              <Affiliation ID="Aff26">
                <OrgDivision>Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute</OrgDivision>
                <OrgName>Brigham and Women’s Hospital, Harvard Medical School</OrgName>
                <OrgAddress>
                  <City>Boston</City>
                  <State>MA</State>
                  <Country>USA</Country>
                </OrgAddress>
              </Affiliation>
            </AuthorGroup>
          </LocEntry>
          <LocEntry>
            <AuthorGroup>
              <Author AffiliationIDS="Aff127">
                <AuthorName DisplayOrder="Western">
                  <GivenName>Alireza</GivenName>
                  <FamilyName>Farabishahadel</FamilyName>
                </AuthorName>
              </Author>
              <Affiliation ID="Aff127">
                <OrgDivision>Department of Internal Medicine</OrgDivision>
                <OrgName>University of Nevada School of Las Vegas</OrgName>
                <OrgAddress>
                  <City>Las Vegas</City>
                  <State>NV</State>
                  <Country>USA</Country>
                </OrgAddress>
              </Affiliation>
            </AuthorGroup>
          </LocEntry>
          <LocEntry>
            <AuthorGroup>
              <Author AffiliationIDS="Aff27">
                <AuthorName DisplayOrder="Western">
                  <GivenName>William</GivenName>
                  <GivenName>D.</GivenName>
                  <FamilyName>Figg</FamilyName>
                </AuthorName>
              </Author>
              <Affiliation ID="Aff27">
                <OrgDivision>Medical Oncology Branch</OrgDivision>
                <OrgName>Center for Cancer Research, National Cancer Institute, National Institute of Health</OrgName>
                <OrgAddress>
                  <City>Bethesda</City>
                  <State>MD</State>
                  <Country>USA</Country>
                </OrgAddress>
              </Affiliation>
            </AuthorGroup>
          </LocEntry>
          <LocEntry>
            <AuthorGroup>
              <Author AffiliationIDS="Aff28">
                <AuthorName DisplayOrder="Western">
                  <GivenName>Antonio</GivenName>
                  <GivenName>Tito</GivenName>
                  <FamilyName>Fojo</FamilyName>
                </AuthorName>
              </Author>
              <Affiliation ID="Aff28">
                <OrgDivision>Experimental Therapeutics Section, Medical Oncology Branch, Center for Cancer Research</OrgDivision>
                <OrgName>National Cancer Institute</OrgName>
                <OrgAddress>
                  <City>Bethesda</City>
                  <State>MD</State>
                  <Country>USA</Country>
                </OrgAddress>
              </Affiliation>
            </AuthorGroup>
          </LocEntry>
          <LocEntry>
            <AuthorGroup>
              <Author AffiliationIDS="Aff29">
                <AuthorName DisplayOrder="Western">
                  <GivenName>Lawrence</GivenName>
                  <FamilyName>Fong</FamilyName>
                </AuthorName>
                <Role>Associate Professor</Role>
              </Author>
              <Affiliation ID="Aff29">
                <OrgDivision>Department of Medicine, Division of Hematology/Oncology</OrgDivision>
                <OrgName>University of California San Francisco</OrgName>
                <OrgAddress>
                  <City>San Francisco</City>
                  <State>CA</State>
                  <Country>USA</Country>
                </OrgAddress>
              </Affiliation>
            </AuthorGroup>
          </LocEntry>
          <LocEntry>
            <AuthorGroup>
              <Author AffiliationIDS="Aff30">
                <AuthorName DisplayOrder="Western">
                  <GivenName>Terence</GivenName>
                  <GivenName>W.</GivenName>
                  <FamilyName>Friedlander</FamilyName>
                </AuthorName>
              </Author>
              <Affiliation ID="Aff30">
                <OrgDivision>Department of Medicine, Division of Hematology/Oncology</OrgDivision>
                <OrgName>University of California San Francisco Medical Center</OrgName>
                <OrgAddress>
                  <City>San Francisco</City>
                  <State>CA</State>
                  <Country>USA</Country>
                </OrgAddress>
              </Affiliation>
            </AuthorGroup>
          </LocEntry>
          <LocEntry>
            <AuthorGroup>
              <Author AffiliationIDS="Aff31">
                <AuthorName DisplayOrder="Western">
                  <GivenName>Mark</GivenName>
                  <GivenName>W.</GivenName>
                  <FamilyName>Frohlich</FamilyName>
                </AuthorName>
                <Role>Sr. Vice President, Clinical Affairs and Chief Medical Officer</Role>
              </Author>
              <Affiliation ID="Aff31">
                <OrgName>Dendreon Corporation</OrgName>
                <OrgAddress>
                  <City>Seattle</City>
                  <State>WA</State>
                  <Country>USA</Country>
                </OrgAddress>
              </Affiliation>
            </AuthorGroup>
          </LocEntry>
          <LocEntry>
            <AuthorGroup>
              <Author AffiliationIDS="Aff32">
                <AuthorName DisplayOrder="Western">
                  <GivenName>Erin</GivenName>
                  <GivenName>R.</GivenName>
                  <FamilyName>Gardner</FamilyName>
                </AuthorName>
              </Author>
              <Affiliation ID="Aff32">
                <OrgName>SAIC-Frederick, Inc., Clinical Pharmacology Program, National Cancer Institute</OrgName>
                <OrgAddress>
                  <City>Frederick</City>
                  <State>MD</State>
                  <Country>USA</Country>
                </OrgAddress>
              </Affiliation>
            </AuthorGroup>
          </LocEntry>
          <LocEntry>
            <AuthorGroup>
              <Author AffiliationIDS="Aff33">
                <AuthorName DisplayOrder="Western">
                  <GivenName>Edward</GivenName>
                  <GivenName>P.</GivenName>
                  <FamilyName>Gelmann</FamilyName>
                </AuthorName>
                <Role>Herbert Irving Comprehensive Cancer Center</Role>
              </Author>
              <Affiliation ID="Aff33">
                <OrgDivision>Division of Hematology/Oncology</OrgDivision>
                <OrgName>Columbia University</OrgName>
                <OrgAddress>
                  <City>New York</City>
                  <State>NY</State>
                  <Country>USA</Country>
                </OrgAddress>
              </Affiliation>
            </AuthorGroup>
          </LocEntry>
          <LocEntry>
            <AuthorGroup>
              <Author AffiliationIDS="Aff34">
                <AuthorName DisplayOrder="Western">
                  <GivenName>Martin</GivenName>
                  <GivenName>E.</GivenName>
                  <FamilyName>Gleave</FamilyName>
                </AuthorName>
              </Author>
              <Affiliation ID="Aff34">
                <OrgDivision>UBC Department of Urologic Sciences, The Vancouver Prostate Center</OrgDivision>
                <OrgName>Vancouver General Hospital, University of British Columbia</OrgName>
                <OrgAddress>
                  <City>Vancouver</City>
                  <State>BC</State>
                  <Country>Canada</Country>
                </OrgAddress>
              </Affiliation>
            </AuthorGroup>
          </LocEntry>
          <LocEntry>
            <AuthorGroup>
              <Author AffiliationIDS="Aff35">
                <AuthorName DisplayOrder="Western">
                  <GivenName>Oscar</GivenName>
                  <GivenName>B.</GivenName>
                  <FamilyName>Goodman</FamilyName>
                </AuthorName>
                <Role>Jr., Assistant Professor</Role>
              </Author>
              <Affiliation ID="Aff35">
                <OrgDivision>Clinical Oncology</OrgDivision>
                <OrgName>Nevada Cancer Institute</OrgName>
                <OrgAddress>
                  <City>Las Vegas</City>
                  <State>NV</State>
                  <Country>USA</Country>
                </OrgAddress>
              </Affiliation>
            </AuthorGroup>
          </LocEntry>
          <LocEntry>
            <AuthorGroup>
              <Author AffiliationIDS="Aff36">
                <AuthorName DisplayOrder="Western">
                  <GivenName>Mitchell</GivenName>
                  <FamilyName>Gross</FamilyName>
                </AuthorName>
                <Role>Director of Experimental Therapeutics</Role>
              </Author>
              <Affiliation ID="Aff36">
                <OrgName>Louis Warschaw Prostate Cancer Center, Cedars-Sinai Medical Center</OrgName>
                <OrgAddress>
                  <City>Los Angeles</City>
                  <State>CA</State>
                  <Country>USA</Country>
                </OrgAddress>
              </Affiliation>
            </AuthorGroup>
          </LocEntry>
          <LocEntry>
            <AuthorGroup>
              <Author AffiliationIDS="Aff37">
                <AuthorName DisplayOrder="Western">
                  <GivenName>James</GivenName>
                  <GivenName>L.</GivenName>
                  <FamilyName>Gulley</FamilyName>
                </AuthorName>
              </Author>
              <Affiliation ID="Aff37">
                <OrgDivision>Laboratory of Tumor Immunology and Biology, Medical Oncology Branch</OrgDivision>
                <OrgName>National Cancer Institute</OrgName>
                <OrgAddress>
                  <City>Bethesda</City>
                  <State>MD</State>
                  <Country>USA</Country>
                </OrgAddress>
              </Affiliation>
            </AuthorGroup>
          </LocEntry>
          <LocEntry>
            <AuthorGroup>
              <Author AffiliationIDS="Aff38">
                <AuthorName DisplayOrder="Western">
                  <GivenName>Christopher</GivenName>
                  <GivenName>L.</GivenName>
                  <FamilyName>Hall</FamilyName>
                </AuthorName>
                <Role>Research Investigator</Role>
              </Author>
              <Affiliation ID="Aff38">
                <OrgDivision>Department of Urology</OrgDivision>
                <OrgName>University of Michigan</OrgName>
                <OrgAddress>
                  <City>Ann Arbor</City>
                  <State>MI</State>
                  <Country>USA</Country>
                </OrgAddress>
              </Affiliation>
            </AuthorGroup>
          </LocEntry>
          <LocEntry>
            <AuthorGroup>
              <Author AffiliationIDS="Aff39">
                <AuthorName DisplayOrder="Western">
                  <GivenName>Patricia</GivenName>
                  <FamilyName>Halterman</FamilyName>
                </AuthorName>
              </Author>
              <Affiliation ID="Aff39">
                <OrgDivision>Clinical Pharmacy</OrgDivision>
                <OrgName>Nevada Cancer Institute</OrgName>
                <OrgAddress>
                  <City>Las Vegas</City>
                  <State>NV</State>
                  <Country>USA</Country>
                </OrgAddress>
              </Affiliation>
            </AuthorGroup>
          </LocEntry>
          <LocEntry>
            <AuthorGroup>
              <Author AffiliationIDS="Aff40">
                <AuthorName DisplayOrder="Western">
                  <GivenName>Andrea</GivenName>
                  <GivenName>L.</GivenName>
                  <FamilyName>Harzstark</FamilyName>
                </AuthorName>
                <Role>Department of Medicine</Role>
              </Author>
              <Affiliation ID="Aff40">
                <OrgDivision>Division of Hematology/Oncology</OrgDivision>
                <OrgName>University of California San Francisco</OrgName>
                <OrgAddress>
                  <City>San Francisco</City>
                  <State>CA</State>
                  <Country>USA</Country>
                </OrgAddress>
              </Affiliation>
            </AuthorGroup>
          </LocEntry>
          <LocEntry>
            <AuthorGroup>
              <Author AffiliationIDS="Aff41">
                <AuthorName DisplayOrder="Western">
                  <GivenName>Hannelore</GivenName>
                  <GivenName>V.</GivenName>
                  <FamilyName>Heemers</FamilyName>
                </AuthorName>
              </Author>
              <Affiliation ID="Aff41">
                <OrgName>Department of Urology, Rosewell Park Cancer Institute</OrgName>
                <OrgAddress>
                  <City>Buffalo</City>
                  <State>NY</State>
                  <Postcode>14263</Postcode>
                  <Country>USA</Country>
                </OrgAddress>
              </Affiliation>
            </AuthorGroup>
          </LocEntry>
          <LocEntry>
            <AuthorGroup>
              <Author AffiliationIDS="Aff42">
                <AuthorName DisplayOrder="Western">
                  <GivenName>Celestia</GivenName>
                  <GivenName>S.</GivenName>
                  <FamilyName>Higano</FamilyName>
                </AuthorName>
              </Author>
              <Affiliation ID="Aff42">
                <OrgDivision>University of Washington</OrgDivision>
                <OrgName>Seattle Cancer Care Alliance</OrgName>
                <OrgAddress>
                  <City>Seattle</City>
                  <State>WA</State>
                  <Country>USA</Country>
                </OrgAddress>
              </Affiliation>
            </AuthorGroup>
          </LocEntry>
          <LocEntry>
            <AuthorGroup>
              <Author AffiliationIDS="Aff43">
                <AuthorName DisplayOrder="Western">
                  <GivenName>Margaret</GivenName>
                  <GivenName>G.</GivenName>
                  <FamilyName>House</FamilyName>
                </AuthorName>
                <Role>Nurse Consultant</Role>
              </Author>
              <Affiliation ID="Aff43">
                <OrgDivision>Division of Cancer Prevention, Department of Health and Human Services</OrgDivision>
                <OrgName>National Cancer Institute</OrgName>
                <OrgAddress>
                  <City>Rockville</City>
                  <State>MD</State>
                  <Country>USA</Country>
                </OrgAddress>
              </Affiliation>
            </AuthorGroup>
          </LocEntry>
          <LocEntry>
            <AuthorGroup>
              <Author AffiliationIDS="Aff44">
                <AuthorName DisplayOrder="Western">
                  <GivenName>Ann</GivenName>
                  <GivenName>W.</GivenName>
                  <FamilyName>Hsing</FamilyName>
                </AuthorName>
                <Role>Senior Investigator</Role>
              </Author>
              <Affiliation ID="Aff44">
                <OrgDivision>Division of Cancer Epidemiology and Genetics</OrgDivision>
                <OrgName>National Cancer Institute, National Institutes of Health</OrgName>
                <OrgAddress>
                  <City>Bethesda</City>
                  <State>MD</State>
                  <Country>USA</Country>
                </OrgAddress>
              </Affiliation>
            </AuthorGroup>
          </LocEntry>
          <LocEntry>
            <AuthorGroup>
              <Author AffiliationIDS="Aff45">
                <AuthorName DisplayOrder="Western">
                  <GivenName>Jiaoti</GivenName>
                  <FamilyName>Huang</FamilyName>
                </AuthorName>
                <Role>Professor</Role>
              </Author>
              <Affiliation ID="Aff45">
                <OrgDivision>Pathology Department</OrgDivision>
                <OrgName>UCLA David Geffen School of Medicine</OrgName>
                <OrgAddress>
                  <City>Los Angeles</City>
                  <State>CA</State>
                  <Country>USA</Country>
                </OrgAddress>
              </Affiliation>
            </AuthorGroup>
          </LocEntry>
          <LocEntry>
            <AuthorGroup>
              <Author AffiliationIDS="Aff46">
                <AuthorName DisplayOrder="Western">
                  <GivenName>Maha</GivenName>
                  <FamilyName>Hussain</FamilyName>
                </AuthorName>
              </Author>
              <Affiliation ID="Aff46">
                <OrgDivision>Comprehensive Cancer Center</OrgDivision>
                <OrgName>University of Michigan</OrgName>
                <OrgAddress>
                  <City>Ann Arbor</City>
                  <State>MI</State>
                  <Country>USA</Country>
                </OrgAddress>
              </Affiliation>
            </AuthorGroup>
          </LocEntry>
          <LocEntry>
            <AuthorGroup>
              <Author AffiliationIDS="Aff47">
                <AuthorName DisplayOrder="Western">
                  <GivenName>Ana</GivenName>
                  <GivenName>R.</GivenName>
                  <FamilyName>Jensen</FamilyName>
                </AuthorName>
              </Author>
              <Affiliation ID="Aff47">
                <OrgDivision>Sections of Hematology/Oncology, Department of Medicine</OrgDivision>
                <OrgName>University of Chicago</OrgName>
                <OrgAddress>
                  <City>Chicago</City>
                  <State>IL</State>
                  <Country>USA</Country>
                </OrgAddress>
              </Affiliation>
            </AuthorGroup>
          </LocEntry>
          <LocEntry>
            <AuthorGroup>
              <Author AffiliationIDS="Aff48">
                <AuthorName DisplayOrder="Western">
                  <GivenName>Evan</GivenName>
                  <GivenName>T.</GivenName>
                  <FamilyName>Keller</FamilyName>
                </AuthorName>
              </Author>
              <Affiliation ID="Aff48">
                <OrgDivision>Department of Urology</OrgDivision>
                <OrgName>University of Michigan</OrgName>
                <OrgAddress>
                  <City>Ann Arbor</City>
                  <State>MI</State>
                  <Country>USA</Country>
                </OrgAddress>
              </Affiliation>
            </AuthorGroup>
          </LocEntry>
          <LocEntry>
            <AuthorGroup>
              <Author AffiliationIDS="Aff49">
                <AuthorName DisplayOrder="Western">
                  <GivenName>William</GivenName>
                  <GivenName>Kevin</GivenName>
                  <FamilyName>Kelly</FamilyName>
                </AuthorName>
                <Role>Solid Tumor Oncology, Department of Medical Oncology, Associate Director of Translation Research</Role>
              </Author>
              <Affiliation ID="Aff49">
                <OrgDivision>Jefferson Kimmel Cancel Center</OrgDivision>
                <OrgName>Thomas Jefferson University</OrgName>
                <OrgAddress>
                  <Street>Suite 314</Street>
                  <City>Philadelphia</City>
                  <State>PA</State>
                  <Postcode>19107</Postcode>
                  <Country>USA</Country>
                </OrgAddress>
              </Affiliation>
            </AuthorGroup>
          </LocEntry>
          <LocEntry>
            <AuthorGroup>
              <Author AffiliationIDS="Aff50">
                <AuthorName DisplayOrder="Western">
                  <GivenName>James</GivenName>
                  <GivenName>R.</GivenName>
                  <FamilyName>Lambert</FamilyName>
                </AuthorName>
                <Role>Assistant Professor</Role>
              </Author>
              <Affiliation ID="Aff50">
                <OrgDivision>Pathology Department</OrgDivision>
                <OrgName>University of Colorado Denver</OrgName>
                <OrgAddress>
                  <City>Aurora</City>
                  <State>CO</State>
                  <Country>USA</Country>
                </OrgAddress>
              </Affiliation>
            </AuthorGroup>
          </LocEntry>
          <LocEntry>
            <AuthorGroup>
              <Author AffiliationIDS="Aff51">
                <AuthorName DisplayOrder="Western">
                  <GivenName>Marshall</GivenName>
                  <GivenName>Scott</GivenName>
                  <FamilyName>Lucia</FamilyName>
                </AuthorName>
              </Author>
              <Affiliation ID="Aff51">
                <OrgDivision>Department of Pathology</OrgDivision>
                <OrgName>University of Colorado, Denver</OrgName>
                <OrgAddress>
                  <City>Aurora</City>
                  <State>CO</State>
                  <Country>USA</Country>
                </OrgAddress>
              </Affiliation>
            </AuthorGroup>
          </LocEntry>
          <LocEntry>
            <AuthorGroup>
              <Author AffiliationIDS="Aff52">
                <AuthorName DisplayOrder="Western">
                  <GivenName>Ravi</GivenName>
                  <GivenName>A.</GivenName>
                  <FamilyName>Madan</FamilyName>
                </AuthorName>
                <Role>Assistant Clinical Investigator</Role>
              </Author>
              <Affiliation ID="Aff52">
                <OrgDivision>Laboratory of Tumor Immunology and Biology, Medical Oncology Branch</OrgDivision>
                <OrgName>National Cancer Institute</OrgName>
                <OrgAddress>
                  <City>Bethesda</City>
                  <State>MD</State>
                  <Country>USA</Country>
                </OrgAddress>
              </Affiliation>
            </AuthorGroup>
          </LocEntry>
          <LocEntry>
            <AuthorGroup>
              <Author AffiliationIDS="Aff53">
                <AuthorName DisplayOrder="Western">
                  <GivenName>Francine</GivenName>
                  <GivenName>Zanchetta</GivenName>
                  <GivenName>Coelho</GivenName>
                  <FamilyName>Marques</FamilyName>
                </AuthorName>
                <Role>Plunkett Chair of Molecular Biology (Medicine)</Role>
              </Author>
              <Affiliation ID="Aff53">
                <OrgDivision>Anatomy Department</OrgDivision>
                <OrgName>The University of Sydney</OrgName>
                <OrgAddress>
                  <City>Sydney</City>
                  <State>NSW</State>
                  <Country>Australia</Country>
                </OrgAddress>
              </Affiliation>
            </AuthorGroup>
          </LocEntry>
          <LocEntry>
            <AuthorGroup>
              <Author AffiliationIDS="Aff54">
                <AuthorName DisplayOrder="Western">
                  <GivenName>Joel</GivenName>
                  <GivenName>B.</GivenName>
                  <FamilyName>Nelson</FamilyName>
                </AuthorName>
              </Author>
              <Affiliation ID="Aff54">
                <OrgDivision>Department of Urology</OrgDivision>
                <OrgName>University of Pittsburgh</OrgName>
                <OrgAddress>
                  <City>Pittsburgh</City>
                  <State>PA</State>
                  <Country>USA</Country>
                </OrgAddress>
              </Affiliation>
            </AuthorGroup>
          </LocEntry>
          <LocEntry>
            <AuthorGroup>
              <Author AffiliationIDS="Aff55">
                <AuthorName DisplayOrder="Western">
                  <GivenName>Edward</GivenName>
                  <GivenName>Macrohon</GivenName>
                  <FamilyName>Nepomuceno</FamilyName>
                </AuthorName>
                <Role>Fellow in Medical Oncology and Hematology</Role>
              </Author>
              <Affiliation ID="Aff55">
                <OrgDivision>Olive View, Department of Medicine</OrgDivision>
                <OrgName>UCLA Medical Center</OrgName>
                <OrgAddress>
                  <City>Sylmar</City>
                  <State>CA</State>
                  <Country>USA</Country>
                </OrgAddress>
              </Affiliation>
            </AuthorGroup>
          </LocEntry>
          <LocEntry>
            <AuthorGroup>
              <Author AffiliationIDS="Aff56">
                <AuthorName DisplayOrder="Western">
                  <GivenName>Yang-Min</GivenName>
                  <FamilyName>Ning</FamilyName>
                </AuthorName>
              </Author>
              <Affiliation ID="Aff56">
                <OrgDivision>Office of Oncology Drug Products</OrgDivision>
                <OrgName>The U.S. Food and Drug Administration</OrgName>
                <OrgAddress>
                  <City>Silver Spring</City>
                  <State>MD</State>
                  <Country>USA</Country>
                </OrgAddress>
              </Affiliation>
            </AuthorGroup>
          </LocEntry>
          <LocEntry>
            <AuthorGroup>
              <Author AffiliationIDS="Aff57">
                <AuthorName DisplayOrder="Western">
                  <GivenName>Junyang</GivenName>
                  <FamilyName>Niu</FamilyName>
                </AuthorName>
                <Role>Professor</Role>
              </Author>
              <Affiliation ID="Aff57">
                <OrgDivision>Pathology Department</OrgDivision>
                <OrgName>Anhui Provincial Hospital</OrgName>
                <OrgAddress>
                  <City>Hefei</City>
                  <State>Anhui Province</State>
                  <Country>China</Country>
                </OrgAddress>
              </Affiliation>
            </AuthorGroup>
          </LocEntry>
          <LocEntry>
            <AuthorGroup>
              <Author AffiliationIDS="Aff58">
                <AuthorName DisplayOrder="Western">
                  <GivenName>William</GivenName>
                  <GivenName>K.</GivenName>
                  <FamilyName>Oh</FamilyName>
                </AuthorName>
              </Author>
              <Affiliation ID="Aff58">
                <OrgDivision>Division of Hematology and Medical Oncology</OrgDivision>
                <OrgName>Dana-Farber Cancer Institute</OrgName>
                <OrgAddress>
                  <City>New York, 10029</City>
                  <State>NY</State>
                  <Country>USA</Country>
                </OrgAddress>
              </Affiliation>
            </AuthorGroup>
          </LocEntry>
          <LocEntry>
            <AuthorGroup>
              <Author AffiliationIDS="Aff59">
                <AuthorName DisplayOrder="Western">
                  <GivenName>Howard</GivenName>
                  <GivenName>L.</GivenName>
                  <FamilyName>Parnes</FamilyName>
                </AuthorName>
              </Author>
              <Affiliation ID="Aff59">
                <OrgDivision>Prostate and Urologic Cancer Research Group, NCI-Division of Cancer Prevention, Center for Cancer Research</OrgDivision>
                <OrgName>National Cancer Institute</OrgName>
                <OrgAddress>
                  <City>Bethesda</City>
                  <State>MD</State>
                  <Country>USA</Country>
                </OrgAddress>
              </Affiliation>
            </AuthorGroup>
          </LocEntry>
          <LocEntry>
            <AuthorGroup>
              <Author AffiliationIDS="Aff60">
                <AuthorName DisplayOrder="Western">
                  <GivenName>Guiseppe</GivenName>
                  <FamilyName>Pasqualetti</FamilyName>
                </AuthorName>
                <Role>Post-doctoral Fellow</Role>
              </Author>
              <Affiliation ID="Aff60">
                <OrgDivision>Division of Pharmacology and Chemotherapy, Department of Internal Medicine</OrgDivision>
                <OrgName>University of Pisa</OrgName>
                <OrgAddress>
                  <City>Pisa</City>
                  <Country>Italy</Country>
                </OrgAddress>
              </Affiliation>
            </AuthorGroup>
          </LocEntry>
          <LocEntry>
            <AuthorGroup>
              <Author AffiliationIDS="Aff61">
                <AuthorName DisplayOrder="Western">
                  <GivenName>Lalit</GivenName>
                  <GivenName>R.</GivenName>
                  <FamilyName>Patel</FamilyName>
                </AuthorName>
                <Role>Research Coordinator</Role>
              </Author>
              <Affiliation ID="Aff61">
                <OrgName>Prostate Cancer Foundation</OrgName>
                <OrgAddress>
                  <City>Santa Monica</City>
                  <State>CA</State>
                  <Country>USA</Country>
                </OrgAddress>
              </Affiliation>
            </AuthorGroup>
          </LocEntry>
          <LocEntry>
            <AuthorGroup>
              <Author AffiliationIDS="Aff62">
                <AuthorName DisplayOrder="Western">
                  <GivenName>Richard</GivenName>
                  <FamilyName>Pazdur</FamilyName>
                </AuthorName>
                <Role>Director</Role>
              </Author>
              <Affiliation ID="Aff62">
                <OrgDivision>Office of Oncology Drug Products</OrgDivision>
                <OrgName>The U.S. Food and Drug Administration</OrgName>
                <OrgAddress>
                  <City>Silver Spring</City>
                  <State>MD</State>
                  <Country>USA</Country>
                </OrgAddress>
              </Affiliation>
            </AuthorGroup>
          </LocEntry>
          <LocEntry>
            <AuthorGroup>
              <Author AffiliationIDS="Aff63">
                <AuthorName DisplayOrder="Western">
                  <GivenName>Daniel</GivenName>
                  <GivenName>P.</GivenName>
                  <FamilyName>Petrylak</FamilyName>
                </AuthorName>
              </Author>
              <Affiliation ID="Aff63">
                <OrgName>Columbia University Medical Center</OrgName>
                <OrgAddress>
                  <City>New York</City>
                  <State>NY</State>
                  <Country>USA</Country>
                </OrgAddress>
              </Affiliation>
            </AuthorGroup>
          </LocEntry>
          <LocEntry>
            <AuthorGroup>
              <Author AffiliationIDS="Aff64">
                <AuthorName DisplayOrder="Western">
                  <GivenName>Courtney</GivenName>
                  <GivenName>K.</GivenName>
                  <FamilyName>Phillips</FamilyName>
                </AuthorName>
                <Role>Assistant Professor of Urology</Role>
              </Author>
              <Affiliation ID="Aff64">
                <OrgDivision>Urology Department</OrgDivision>
                <OrgName>Mount Sinai School of Medicine</OrgName>
                <OrgAddress>
                  <City>New York</City>
                  <State>NY</State>
                  <Country>USA</Country>
                </OrgAddress>
              </Affiliation>
            </AuthorGroup>
          </LocEntry>
          <LocEntry>
            <AuthorGroup>
              <Author AffiliationIDS="Aff65">
                <AuthorName DisplayOrder="Western">
                  <GivenName>Elizabeth</GivenName>
                  <GivenName>A.</GivenName>
                  <FamilyName>Platz</FamilyName>
                </AuthorName>
              </Author>
              <Affiliation ID="Aff65">
                <OrgDivision>Department of Epidemiology</OrgDivision>
                <OrgName>Johns Hopkins Bloomberg School of Public Health</OrgName>
                <OrgAddress>
                  <City>Baltimore</City>
                  <State>MD</State>
                  <Country>USA</Country>
                </OrgAddress>
              </Affiliation>
            </AuthorGroup>
          </LocEntry>
          <LocEntry>
            <AuthorGroup>
              <Author AffiliationIDS="Aff66">
                <AuthorName DisplayOrder="Western">
                  <GivenName>Edwin</GivenName>
                  <GivenName>M.</GivenName>
                  <FamilyName>Posadas</FamilyName>
                </AuthorName>
              </Author>
              <Affiliation ID="Aff66">
                <OrgDivision>Section of Hematology/Oncology, Department of Medicine</OrgDivision>
                <OrgName>University of Chicago</OrgName>
                <OrgAddress>
                  <City>Chicago</City>
                  <State>IL 60637</State>
                  <Country>USA</Country>
                </OrgAddress>
              </Affiliation>
            </AuthorGroup>
          </LocEntry>
          <LocEntry>
            <AuthorGroup>
              <Author AffiliationIDS="Aff67">
                <AuthorName DisplayOrder="Western">
                  <GivenName>Douglas</GivenName>
                  <GivenName>K.</GivenName>
                  <FamilyName>Price</FamilyName>
                </AuthorName>
                <Role>Medical Oncology Branch</Role>
              </Author>
              <Affiliation ID="Aff67">
                <OrgName>National Cancer Institute, National Institutes of Health</OrgName>
                <OrgAddress>
                  <City>Bethesda</City>
                  <State>MD</State>
                  <Country>USA</Country>
                </OrgAddress>
              </Affiliation>
            </AuthorGroup>
          </LocEntry>
          <LocEntry>
            <AuthorGroup>
              <Author AffiliationIDS="Aff68">
                <AuthorName DisplayOrder="Western">
                  <GivenName>Juergen</GivenName>
                  <GivenName>K.</GivenName>
                  <GivenName>V.</GivenName>
                  <FamilyName>Reichardt</FamilyName>
                </AuthorName>
                <Role>Plunkett Chair of Molecular Biology (Medicine)</Role>
              </Author>
              <Affiliation ID="Aff68">
                <OrgName>The University of Sydney</OrgName>
                <OrgAddress>
                  <City>Sydney</City>
                  <State>NSW</State>
                  <Country>Australia</Country>
                </OrgAddress>
              </Affiliation>
            </AuthorGroup>
          </LocEntry>
          <LocEntry>
            <AuthorGroup>
              <Author AffiliationIDS="Aff69">
                <AuthorName DisplayOrder="Western">
                  <GivenName>Erin</GivenName>
                  <GivenName>L.</GivenName>
                  <FamilyName>Richman</FamilyName>
                </AuthorName>
              </Author>
              <Affiliation ID="Aff69">
                <OrgDivision>Nutrition Department</OrgDivision>
                <OrgName>Harvard School of Public Health</OrgName>
                <OrgAddress>
                  <City>Boston</City>
                  <State>MA</State>
                  <Country>USA</Country>
                </OrgAddress>
              </Affiliation>
            </AuthorGroup>
          </LocEntry>
          <LocEntry>
            <AuthorGroup>
              <Author AffiliationIDS="Aff70">
                <AuthorName DisplayOrder="Western">
                  <GivenName>Jonathan</GivenName>
                  <FamilyName>Rosenberg</FamilyName>
                </AuthorName>
              </Author>
              <Affiliation ID="Aff70">
                <OrgDivision>Lank Center for Genitourinary Oncology</OrgDivision>
                <OrgName>Dana-Farber Cancer Institute</OrgName>
                <OrgAddress>
                  <City>Boston</City>
                  <State>MA</State>
                  <Country>USA</Country>
                </OrgAddress>
              </Affiliation>
            </AuthorGroup>
          </LocEntry>
          <LocEntry>
            <AuthorGroup>
              <Author AffiliationIDS="Aff71">
                <AuthorName DisplayOrder="Western">
                  <GivenName>Charles</GivenName>
                  <GivenName>J.</GivenName>
                  <FamilyName>Ryan</FamilyName>
                </AuthorName>
              </Author>
              <Affiliation ID="Aff71">
                <OrgDivision>Department of Medicine</OrgDivision>
                <OrgName>University of California San Francisco</OrgName>
                <OrgAddress>
                  <City>San Francisco</City>
                  <State>CA</State>
                  <Country>USA</Country>
                </OrgAddress>
              </Affiliation>
            </AuthorGroup>
          </LocEntry>
          <LocEntry>
            <AuthorGroup>
              <Author AffiliationIDS="Aff72">
                <AuthorName DisplayOrder="Western">
                  <GivenName>Oliver</GivenName>
                  <FamilyName>Sartor</FamilyName>
                </AuthorName>
              </Author>
              <Affiliation ID="Aff72">
                <OrgDivision>Departments of Medicine and Urology</OrgDivision>
                <OrgName>Tulane Medical School</OrgName>
                <OrgAddress>
                  <City>New Orleans</City>
                  <State>LA</State>
                  <Country>USA</Country>
                </OrgAddress>
              </Affiliation>
            </AuthorGroup>
          </LocEntry>
          <LocEntry>
            <AuthorGroup>
              <Author AffiliationIDS="Aff73">
                <AuthorName DisplayOrder="Western">
                  <GivenName>Philip</GivenName>
                  <GivenName>J.</GivenName>
                  <FamilyName>Saylor</FamilyName>
                </AuthorName>
              </Author>
              <Affiliation ID="Aff73">
                <OrgDivision>Department of Medicine, Division of Hematology/Oncology</OrgDivision>
                <OrgName>Massachusetts General Hospital Cancer Center</OrgName>
                <OrgAddress>
                  <City>Boston</City>
                  <State>MA</State>
                  <Country>USA</Country>
                </OrgAddress>
              </Affiliation>
            </AuthorGroup>
          </LocEntry>
          <LocEntry>
            <AuthorGroup>
              <Author AffiliationIDS="Aff75">
                <AuthorName DisplayOrder="Western">
                  <GivenName>Andrew</GivenName>
                  <GivenName>V.</GivenName>
                  <FamilyName>Schally</FamilyName>
                </AuthorName>
                <Role>Department of Veterans Affairs, VA Research Services, Veterans Affairs Medical Center, Miami FL, USA, and Division of Hematology/Oncology and Division of Endocrinology</Role>
              </Author>
              <Affiliation ID="Aff75">
                <OrgDivision>Departments of Pathology and Medicine</OrgDivision>
                <OrgName>Miller School of Medicine, University of Miami</OrgName>
                <OrgAddress>
                  <City>Miami</City>
                  <State>FL</State>
                  <Country>USA</Country>
                </OrgAddress>
              </Affiliation>
            </AuthorGroup>
          </LocEntry>
          <LocEntry>
            <AuthorGroup>
              <Author AffiliationIDS="Aff76">
                <AuthorName DisplayOrder="Western">
                  <GivenName>Jeffrey</GivenName>
                  <FamilyName>Schlom</FamilyName>
                </AuthorName>
                <Role>Chief</Role>
              </Author>
              <Affiliation ID="Aff76">
                <OrgDivision>Laboratory of Tumor Immunology and Biology, Center for Cancer Research</OrgDivision>
                <OrgName>National Cancer Institute, National Institutes of Health</OrgName>
                <OrgAddress>
                  <City>Bethesda</City>
                  <State>MD</State>
                  <Country>USA</Country>
                </OrgAddress>
              </Affiliation>
            </AuthorGroup>
          </LocEntry>
          <LocEntry>
            <AuthorGroup>
              <Author AffiliationIDS="Aff77">
                <AuthorName DisplayOrder="Western">
                  <GivenName>Nima</GivenName>
                  <FamilyName>Sharifi</FamilyName>
                </AuthorName>
              </Author>
              <Affiliation ID="Aff77">
                <OrgDivision>Division of Hematology/Oncology</OrgDivision>
                <OrgName>University of Texas Southwestern Medical Center</OrgName>
                <OrgAddress>
                  <City>Dallas</City>
                  <State>TX</State>
                  <Country>USA</Country>
                </OrgAddress>
              </Affiliation>
            </AuthorGroup>
          </LocEntry>
          <LocEntry>
            <AuthorGroup>
              <Author AffiliationIDS="Aff78">
                <AuthorName DisplayOrder="Western">
                  <GivenName>Howard</GivenName>
                  <GivenName>C.</GivenName>
                  <FamilyName>Shen</FamilyName>
                </AuthorName>
                <Role>Research Fellow</Role>
              </Author>
              <Affiliation ID="Aff78">
                <OrgDivision>Department of Medicine, Bth Israel Deaconess Medical Center</OrgDivision>
                <OrgName>Harvard Medical School</OrgName>
                <OrgAddress>
                  <City>Boston</City>
                  <State>MA</State>
                  <Country>USA</Country>
                </OrgAddress>
              </Affiliation>
            </AuthorGroup>
          </LocEntry>
          <LocEntry>
            <AuthorGroup>
              <Author AffiliationIDS="Aff79">
                <AuthorName DisplayOrder="Western">
                  <GivenName>Jonathan</GivenName>
                  <GivenName>W.</GivenName>
                  <FamilyName>Simons</FamilyName>
                </AuthorName>
              </Author>
              <Affiliation ID="Aff79">
                <OrgName>Prostate Cancer Foundation</OrgName>
                <OrgAddress>
                  <City>Santa Monica</City>
                  <State>CA</State>
                  <Country>USA</Country>
                </OrgAddress>
              </Affiliation>
            </AuthorGroup>
          </LocEntry>
          <LocEntry>
            <AuthorGroup>
              <Author AffiliationIDS="Aff80">
                <AuthorName DisplayOrder="Western">
                  <GivenName>Tristan</GivenName>
                  <GivenName>M.</GivenName>
                  <FamilyName>Sissung</FamilyName>
                </AuthorName>
              </Author>
              <Affiliation ID="Aff80">
                <OrgDivision>Medical Oncology Branch, Center for Cancer Research</OrgDivision>
                <OrgName>National Cancer Institutes, National Institute of Health</OrgName>
                <OrgAddress>
                  <City>Bethesda</City>
                  <State>MD</State>
                  <Country>USA</Country>
                </OrgAddress>
              </Affiliation>
            </AuthorGroup>
          </LocEntry>
          <LocEntry>
            <AuthorGroup>
              <Author AffiliationIDS="Aff81">
                <AuthorName DisplayOrder="Western">
                  <GivenName>Matthew</GivenName>
                  <GivenName>R.</GivenName>
                  <FamilyName>Smith</FamilyName>
                </AuthorName>
                <Role>Associate Professor</Role>
              </Author>
              <Affiliation ID="Aff81">
                <OrgDivision>Division of Hematology/Oncology, Department of Medicine</OrgDivision>
                <OrgName>Massachusetts General Hospital Cancer Center, Harvard Medical School</OrgName>
                <OrgAddress>
                  <City>Boston</City>
                  <State>MA</State>
                  <Country>USA</Country>
                </OrgAddress>
              </Affiliation>
            </AuthorGroup>
          </LocEntry>
          <LocEntry>
            <AuthorGroup>
              <Author AffiliationIDS="Aff82">
                <AuthorName DisplayOrder="Western">
                  <GivenName>Russell</GivenName>
                  <GivenName>Z.</GivenName>
                  <FamilyName>Szmulewitz</FamilyName>
                </AuthorName>
                <Role>Instructor</Role>
              </Author>
              <Affiliation ID="Aff82">
                <OrgDivision>Sections of Hematology/Oncology, Department of Medicine</OrgDivision>
                <OrgName>University of Chicago</OrgName>
                <OrgAddress>
                  <City>Chicago</City>
                  <State>IL</State>
                  <Country>USA</Country>
                </OrgAddress>
              </Affiliation>
            </AuthorGroup>
          </LocEntry>
          <LocEntry>
            <AuthorGroup>
              <Author AffiliationIDS="Aff83">
                <AuthorName DisplayOrder="Western">
                  <GivenName>Joseph</GivenName>
                  <GivenName>A.</GivenName>
                  <FamilyName>Tangrea</FamilyName>
                </AuthorName>
                <Role>Program Director</Role>
              </Author>
              <Affiliation ID="Aff83">
                <OrgDivision>Department of Health and Human Services</OrgDivision>
                <OrgName>National Cancer Institute</OrgName>
                <OrgAddress>
                  <City>Rockville</City>
                  <State>MD</State>
                  <Country>USA</Country>
                </OrgAddress>
              </Affiliation>
            </AuthorGroup>
          </LocEntry>
          <LocEntry>
            <AuthorGroup>
              <Author AffiliationIDS="Aff84">
                <AuthorName DisplayOrder="Western">
                  <GivenName>Mary-Ellen</GivenName>
                  <FamilyName>Taplin</FamilyName>
                </AuthorName>
                <Role>Associate Professor of Medicine</Role>
              </Author>
              <Affiliation ID="Aff84">
                <OrgDivision>Lank Center for Genitourinary, Oncology</OrgDivision>
                <OrgName>Harvard Medical School, Dana-Farber Cancer Institute</OrgName>
                <OrgAddress>
                  <City>Boston</City>
                  <State>MA</State>
                  <Country>USA</Country>
                </OrgAddress>
              </Affiliation>
            </AuthorGroup>
          </LocEntry>
          <LocEntry>
            <AuthorGroup>
              <Author AffiliationIDS="Aff85">
                <AuthorName DisplayOrder="Western">
                  <GivenName>Donald</GivenName>
                  <GivenName>J.</GivenName>
                  <FamilyName>Tindall</FamilyName>
                </AuthorName>
                <Role>Professor</Role>
              </Author>
              <Affiliation ID="Aff85">
                <OrgDivision>Department of Urology Research</OrgDivision>
                <OrgName>Mayo Clinic</OrgName>
                <OrgAddress>
                  <City>Rochester</City>
                  <State>MN</State>
                  <Country>USA</Country>
                </OrgAddress>
              </Affiliation>
            </AuthorGroup>
          </LocEntry>
          <LocEntry>
            <AuthorGroup>
              <Author AffiliationIDS="Aff86">
                <AuthorName DisplayOrder="Western">
                  <GivenName>Damerla</GivenName>
                  <GivenName>R.</GivenName>
                  <FamilyName>Venugopal</FamilyName>
                </AuthorName>
              </Author>
              <Affiliation ID="Aff86">
                <OrgDivision>Section of Hematology-Oncology, Department of Medical Oncology</OrgDivision>
                <OrgName>Tulane Medical School</OrgName>
                <OrgAddress>
                  <City>New Orleans</City>
                  <State>LA</State>
                  <Country>USA</Country>
                </OrgAddress>
              </Affiliation>
            </AuthorGroup>
          </LocEntry>
          <LocEntry>
            <AuthorGroup>
              <Author AffiliationIDS="Aff87">
                <AuthorName DisplayOrder="Western">
                  <GivenName>Nicholas</GivenName>
                  <GivenName>J.</GivenName>
                  <FamilyName>Vogelzang</FamilyName>
                </AuthorName>
                <Role>Professor, Director</Role>
              </Author>
              <Affiliation ID="Aff87">
                <OrgDivision>Medical Oncology</OrgDivision>
                <OrgName>Nevada Cancer Institute, University of Nevada School of Medicine</OrgName>
                <OrgAddress>
                  <City>Las Vegas</City>
                  <State>NV</State>
                  <Country>USA</Country>
                </OrgAddress>
              </Affiliation>
            </AuthorGroup>
          </LocEntry>
          <LocEntry>
            <AuthorGroup>
              <Author AffiliationIDS="Aff88">
                <AuthorName DisplayOrder="Western">
                  <GivenName>Yuzhuo</GivenName>
                  <FamilyName>Wang</FamilyName>
                </AuthorName>
                <Role>Senior Scientist</Role>
              </Author>
              <Affiliation ID="Aff88">
                <OrgDivision>The Vancouver Prostate Centre</OrgDivision>
                <OrgName>Vancouver General Hospital, University of British Columbia</OrgName>
                <OrgAddress>
                  <City>Vancouver</City>
                  <State>BC</State>
                  <Country>Canada</Country>
                </OrgAddress>
              </Affiliation>
            </AuthorGroup>
          </LocEntry>
        </Loc>
      </BodyFrontmatter>
      <BodyRef FileRef="BodyRef/PDF/978-1-60327-829-4_BookFrontMatter.pdf" OutputMedium="Online" PDFType="Typeset" TargetType="OnlinePDF"/>
    </BookFrontmatter>
  </Book>
</Publisher>
